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Abstract 
Polypropionates represent a large family of natural products and several strategies have 
been developed for their synthesis.  The aldol reaction is one of the most important tools for 
the construction of polypropionate natural products.  The Ward group has developed an 
approach to polypropionate natural products based on sequential aldol reactions of thiopyran 
building blocks.  The Thiopyran Route to Polypropionates (TR2P) involves the stepwise aldol 
reactions of 15 and 16 to rapidly access stereochemically complex tetrapropionate and 
hexapropionate synthons in a few steps.  The current work describes the effort to prepare 
enantioenriched 17-AA and/or 17-SA through chiral transition metal based Lewis acids (176) 
and chiral organocatalysts (48, 179) with chelating Lewis acids.  The preparation of non-Felkin 
tetrapropionate and hexapropionate synthons through the use of a weak base in conjunction 
with a Lewis acid was developed. 
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In section 2.1, the application of bis(oxazoline) ligands to the aldol reaction of 15 with 25 
is discussed.  Complexes with metal salts of bis(oxazoline) ligands (176) are unable to catalyze 
any aldol reaction between 15 and 25.  Other Lewis acidic transition metal salts without any 
ligands were also tried; however none could catalyze the aldol reaction between 15 and 25. 
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In section 2.2, a modification of the (S)-5-(pyrrolidin-2-yl)tetrazole (48) catalyzed 
reaction is presented.  After optimization efforts, the diastereoselectivity could not be 
improved to make the 17-AA as the major adduct formed.   
In section 2.3, the novel trans-N,N-dialkylated diaminocyclohexane catalyst (179) was 
applied to the aldol reaction of 15 and 16.  In all cases, the enantioselectivity and yield was low 
and it was determined that the catalyst was simply acting as a base and deprotonating ketone 
16 to form the magnesium enolate. 
Section 2.4 describes the use of a weak base in combination with a Lewis acid for mono-
aldol formation.  The MgBr2·OEt2 promoted aldol reaction of 15 and 16 was studied. The results 
show that the MgBr2·OEt2 and i-Pr2EtN promoted aldol reaction of aldehyde 15 and ketone 16 
can produce the non-Felkin adducts as a 2.2:1 mixture of 17-SA and 17-AA respectively in 70% 
yield.   
After exploration of the MgBr2·OEt2 promoted aldol reaction of 15 with 16, the 
MgBr2·OEt2 and i-Pr2EtN promoted aldol reaction is applied to the aldol reaction of 15 with 17 
and these results are presented in section 2.5. Reactions of 17-SA-TES, 17-AA-TES, 17-SA-
MOM, 17-AS-TES and 17-SS-TES with 15 are highly diastereoselective: only 2 of 8 possible 
diastereomers are detected in moderate yield.  After deprotection of the MOM and TES groups, 
three (18-SA-trans-SA, 18-SA-trans-AA, and 18-AA-trans-AA) of the previously unknown six bis-
aldol diastereomers of 18 are available via this route.  The cis-substituted bis-aldols adducts 
(18-SA-cis-SA, 18-SA-cis-AA, and 18-AA-cis-AA) are obtained through isomerization. 
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In section 3.6, the relative configuration of aldol diastereomers of 18 are determined 
using NMR methods, chemical synthesis (deprotection, reduction) and X-ray techniques. 
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1. INTRODUCTION 
1.1. Polypropionates and the Thiopyran Route to 
Polypropionates 
 
The synthesis of naturally occurring compounds by chemical methods has prompted the 
development of methodologies to access these often synthetically challenging structures.1  
Polyketides are a large class of natural products that are formed from the stepwise 
condensation of acetate units derived from the building block acetyl co-enzyme A.  
Polypropionates are a subgroup of polyketides that is characterized by a carbon chain with 
alternating methyl and oxygen (hydroxy or oxo) functionalities (Scheme 1).1  This characteristic 
sequence is often part of a larger structure but is a major contributor to the stereochemical 
complexity of this class of natural products.  Polypropionates are interesting synthetic targets 
due to their structural complexity and diverse biological activities including showing cytotoxic, 
antibiotic, antifungal and antiviral properties.2  Many synthetic methods have been developed 
to access these complex natural products including reductive couplings, crotylations, 
allenylations, selective radical processes, sequential substitution, epoxide openings, 
rearrangement and intramolecular approaches.1   The aldol reaction is one of the most 
important tools for the construction of polypropionate natural products.  Versatile 
stereochemical control in aldol reactions is possible due to recent advances in aldol 
methodology.  Specifically, modern aldol methods for the total synthesis of polyketides include 
a variety of metal enolates (lithium, titanium, boron, tin enolates), Lewis acid and base 
catalyzed aldol reactions, aldol reactions catalyzed by organocatalysts as well as aldol reactions 
catalyzed by enzymes (biocatalytic).3 
O OO
1  
Scheme 1.  Characteristic sequence of polypropionates 1. 
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The aldol reaction is a versatile and widely used reaction to install the alternating oxo 
and methyl functionalities present in polypropionates (Scheme 2).  Many factors influence the 
relative topicity (i.e. anti or syn relative configuration) of the aldol reaction.  The nature of the 
enolate donor has a large effect.  In general, Z-enolates give syn aldols and E-enolates give anti 
aldols predominantly.  Zimmerman and Traxler proposed a model to account for these 
observations.4  The Zimmerman-Traxler transition state model suggests intramolecular 
coordination of the aldehyde to the metal cation of the enolate, resulting in a closed six-
membered ring chairlike transition state.  The stereoselectivity of the reaction is governed by 
minimization of the 1,3-diaxial interactions between R1 and R2 in 6 versus 8, and 11 versus 13, 
which leads to the observed relative topicity (Scheme 3). 
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Scheme 2.  Propionate aldol reaction. 
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Scheme 3.  Zimmerman-Traxler transition state model for addition of a metal enolate to an 
aldehyde. 
The Ward group has developed an approach to polypropionate natural products based 
on sequential aldol couplings of thiopyran building blocks (Scheme 4).5-13  Central to this 
strategy is the ability to control the stereochemical outcome of aldol couplings of inexpensive 
and easy to access starting materials 15 and 16 (Scheme 4).  An aldol reaction of 15 and 16 
produces the tetrapropionate synthon 17 (mono-aldol adduct) where 4 possible diastereomers 
can be produced.  A second aldol reaction of 15 with 17 generates the hexapropionate synthon 
18 (bis-aldol adduct) where 20 diastereomers are possible.  
Both aldehyde 15 and ketone 16 are accessible from the common reagent dimethyl 3,3’-
thiobispropanoate 19 on multigram scale in 4 and 2 steps, respectively (Scheme 5).6, 7   
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Scheme 4.  Thiopyran Route to Polypropionates Synthetic Strategy. 
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Scheme 5.  Synthesis of building blocks 15 and 16.   
The Thiopyran Route to Polypropionates (TR2P) involves stepwise aldol reactions of 15 
and 16 to rapidly access stereochemically complex polypropionate synthons in a few steps.6, 7  
Access to all four diastereomers of the first aldol reaction from the same starting materials is 
possible by varying the reaction conditions (Scheme 6).7, 8  17-AS is synthesized via the ‘amine-
free’ lithium enolate of 16 proceeding through a closed transition state and Felkin addition to 
chiral aldehyde 15 (Scheme 7).  17-SS is synthesized through a Mukaiyama type aldol reaction 
of 26 with 15 promoted by the Lewis acid TiCl4 proceeding through an open transition sate and 
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Felkin addition to chiral aldehyde 15 (Scheme 7).  MgBr2
.OEt2 is used to generate the non-Felkin 
first aldol adducts 17-SA and 17-AA in a 3:1 ratio.  They are produced via non-Felkin addition to 
chiral aldehyde 15 through an open and closed transition state as seen in Scheme 8.  
Mukaiyama type aldol reactions of 26 and 15 mediated by MgBr2·OEt2 are highly non-Felkin 
selective.  This can be rationalized by assuming that the Mg2+ forms a complex (31 and 32) with 
simultaneous coordination to the carbonyl oxygen and the cis oxygen of the ketal group of 15 
(Scheme 8). 
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Scheme 6.  Mono-aldol formation and isomerization. 
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Scheme 7.  Proposed nonchelation transition state for Felkin addition to 15. 
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Scheme 8.  Proposed chelation transition state for non-Felkin addition of 25 to 15. 
Synthetically useful syn-anti isomerization reactions of aldol adducts have been 
developed by the Ward group.8  Syn-anti isomerization can occur by two distinct mechanisms: i) 
via retroaldol-aldol or ii) via keto-enol tautomerization.  For adducts such as 17 with three 
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stereocenters, these mechanisms can be distinguished by examining the product distribution.  
If the isomerization occurs via a retroaldol-aldol process, isomerization would be expected to 
produce a mixture of all four possible diastereomers in a ratio reflecting their relative 
thermodynamic stability.  However, if the reaction occurs via a keto-enol tautomerization, only 
2 diastereomers are possible.  Isomerization of each of the diastereomers of 17 revealed that 
the reaction occurs with little elimination and little retro-aldol.  In each case, only the pair of 
diastereomers related by keto-enol tautomerism was present and other aldol isomers from 
retroaldol-aldol followed by a subsequent aldol reaction were not detected.  Thus, it was 
concluded that the isomerization occurs via a keto-enol tautomerization.    
This isomerization process has proven useful both as a tool for structure determination 
and as a viable method to obtain certain aldol diastereomers.  For example, 17-AA is the minor 
adduct obtained from the MgBr2·OEt2-mediated aldol reaction of 15 with 26.  However, this 
adduct can be obtained by isomerization of 17-SA, the major adduct from that aldol reaction 
(Scheme 9).  Similarly, the readily obtained enantiopure adduct 17-AS can be efficiently 
isomerized to enantiopure 17-SS (Scheme 10). 
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Scheme 9.  Isomerization of non-Felkin first aldol products.8 
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Scheme 10.  Isomerization of Felkin first aldol products.9 
The second aldol reaction of each of the four diastereomers of 17 with 15 has been 
explored.  For each of the four possible diastereomers of 17, an aldol reaction with racemic 15 
can produce up to eight bis-aldol diastereomers 18 (Scheme 11).  Nonetheless, these reactions 
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can be conducted with remarkable stereoselectivity.  Depending on the reaction conditions and 
whether the OH group is protected or not, each of the diastereomers of 17 can produce any 
one of three diastereomers of 18 with high selectivity (Scheme 12).  Accordingly, 11 of 20 
possible diastereomers of 18 can be obtained selectively in only 6-7 steps from 19. 
S S
OO
OOR
Second aldol
S S
OO
OOR
S
HO
OOS
H
O
O O
(±)-15
17
(any of 4 diastereomers)
S S
OO
OOR
S
HO
OO
S S
OO
OOR
S
HO
OO
S S
OO
OOR
S
HO
OO
S S
OO
OOR
S
HO
OO
S S
OO
OOR
S
HO
OO
S S
OO
OOR
S
HO
OO
S S
OO
OOR
S
HO
OO
35
37
39
41
36
38
40
42  
Scheme 11.  Eight bis-aldol diastereomers possible from any diastereomer of 17. 
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Scheme 12.  Kinetic resolution to selectively give enantioenriched 43, 44 and 45.10 
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The generality of the isomerization process was extended to the bis-aldol diastereomers 
18.  The bis-aldols 18 are able to isomerize at two sites, producing 3 or 4 diastereomers 
depending on the relative configuration at C-1’ and C-6’ compared to that at C-1’’ and C-6’’.  
When these relative configurations are the same (i.e., both syn or both anti), a set of three 
diastereomers are interrelated via isomerization by keto-enol tautomerism (Scheme 13 and 
Scheme 14).  However, when these relative configurations are different (i.e. one syn and one 
anti), isomerization produces a set of four diastereomers (Scheme 15 and Scheme 16).  Using 
the isomerization protocol, three new diastereomers of 18 were isolated: 18-SS-cis-SS (Scheme 
14), 18-SA-cis-SS (Scheme 15) and 18-AA-cis-SS (Scheme 16). 
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Scheme 13.  Imidazole catalyzed isomerization to produce 18-AS-trans-AS:18-AS-cis-SS:18-SS-
trans-SS (3:6.2:1).8 
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Scheme 14.  Imidazole catalyzed isomerization to produce 18-SS-cis-SS:18-AS-trans-SS:18-AS-
cis-AS (3.0:6.2:1).8 
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Scheme 15.  Equilibrium in 0.8 M imidazole in CH2Cl2 after 20 hours at room temperature to 
produce 18-AA-trans-SS:18-AA-cis-AS:18-SA-trans-AS:18-SA-cis-SS (31:13:19:37).11 
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Scheme 16.  Equilibrium in 0.2 M imidazole in CH2Cl2 after 6 days at room temperature to 
produce 18-SA-trans-SS:18-SA-cis-AS:18-AA-trans-AS:18-AA-cis-SS (36:21:32:1).11 
At the outset of this project, 14 of the 20 possible diastereomers of 18 had been 
synthesized; 11 of these are available stereoselectively and 3 by isomerization.  The remaining 
six diastereomers all have the common feature of 1’, 6’ anti and 1”, 6” anti relative topicity, 
arising from non-Felkin1  addition to aldehyde 15 (Scheme 17).   
                                                          
1
 Non-Felkin refers to adducts resulting from addition of the non-Felkin face of aldehyde 15 resulting in adducts 
with (1’R*, 6”S*) relative configuration. 
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Scheme 17.  The six hitherto unsynthesized bis-aldol diastereomers of the TR2P. 
In nature, chiral polypropionates are usually found in enantiopure form.  Using the 
TR2P, enantiopure adducts can be made via two methods.  One option involves synthesizing 
enantiopure aldehyde (Scheme 5); however, the synthesis is difficult to scale up.12  A second 
alternative is to employ an chiral mediator to generate enantioenriched aldol adducts from 
racemic aldehyde.  This latter strategy is shorter and more efficient than synthesizing 
enantiopure aldehyde.  By using the organocatalyst (S)-5-(pyrrolidin-2-yl)tetrazole 48, the 
synthesis of enantiopure (-)-17-AS (>98% ee) can be performed on large scale with high yield 
(Scheme 19).9  Enantiopure 17-SS is easily made from 17-AS via isomerization as previously 
discussed (Scheme 10).8  Thus, both aldol adducts 17-AS and 17-SS derived from Felkin addition 
of 16 to 15 can be obtained in enantiopure form in 5 and 6 steps respectively from dimethyl 
3,3’-thiobispropanoate 19.   The current method to synthesize the non-Felkin aldol adducts 17-
AA and 17-SA requires the enantiopure aldehyde 15. 
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Scheme 18.  Synthesis of enantioenriched (R)-1 by enantioselective deprotonation.12 
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Scheme 19.  Synthesis of non-racemic 17-AS.9 
1.2. Soft-enolization methodology 
Using a weak base in combination with a Lewis acid to generate an enolate has been 
referred to as soft enolization.  As will be discussed in the results and discussion, the soft 
enolization methodology was applied to the TR2P for the formation of mono-aldol adducts 17 
and bis-aldol adducts 18.  A review of the literature on this methodology is presented below. 
Enolates made via a weak base and Lewis acid are formed under mild conditions 
without having to work at low temperatures and under vigorous exclusion of air and moisture.  
The Lewis acid coordinates to the carbonyl oxygen and thereby increases the acidity of the α-
proton so that a weak base is able to deprotonate it reversibly (Scheme 20). This soft 
enolization methodology has been applied towards different types of reactions including aldol 
reactions of thioesters, four component cascade aldol reactions, a Morita-Baylis-Hilman 
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reaction equivalent, Mannich addition, direct crossed Claisen coupling of thioesters and 
towards the synthesis of β-diketones.13, 18 
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Scheme 20.  Enolate formation via a weak base and Lewis acid. 
Coltart has used soft enolization for aldol reactions of simple thioesters.13, 14  Of the 
metal salts examined including zinc(II) chloride, copper(II) acetate, and nickel(II) bromide, only 
magnesium iodide and magnesium bromide could mediate the reaction between benzyl 
acetate (53) and benzaldehyde (54) (Scheme 21).13  The scope of the reaction was expanded by 
using thioesters (Table 1).13 
OBn
O
PhCHO (54), MgI2,
i-Pr2NEt, CH2Cl2
20 h; 46% Ph OBn
OH O
53 55  
Scheme 21.  MgI2 mediated aldol reaction between benzyl acetate (53) and benzaldehyde (54). 
Table 1.  Screening of thioesters 55-60 in the MgI2 mediated aldol reaction with benzaldehyde 
54 
SR
O
1 equiv PhCHO (54), 
1.2 equiv MgI2,
Ph SR
OH O
1.3 equiv i-Pr2NEt, 
CH2Cl2 (0.2 M)  
Entry Thioester  
R = 
Time (min) Isolated yield (%) 
1 Bn (55) 25 95 
2 Ph (56) 20 94 
3 p-OMe-Ph (57) 20 98 
14 
 
4 o-OMe-Ph (58) 20 96 
5 p-NO2-Ph (59) 60 92 
6 -CH2-furan (60) 30 96 
 
The cheaper MgBr2·OEt2 could easily be substituted for MgI2.  No increase in yield or 
decrease in reaction time was observed when anhydrous CH2Cl2 was used, nor when the 
reaction was performed with the strict exclusion of air and moisture under an argon 
atmosphere.  Other solvents were tried including tetrahydrofuran, diethyl ether, N,N-
dimethylformamide, ethyl acetate, benzene, and toluene but lead to no improvement in yield.  
Bases explored include triethylamine, pyridine, 5-methoxybenzimidazole, 2,6-lutidine, 1,8-
diazabicyclo[5.4.0]undec-7-ene, 1,5-diazabicyclo[4.3.0]non-5-ene, and 2-tert-butyl-1,1,3,3-
tetramethylguanidine.  However, N-diisopropyl-N-ethylamine (i-Pr2NEt) was found to be the 
superior base.  Substituted aromatic and aliphatic aldehydes could also perform the direct aldol 
addition with thioesters in high yield and low reaction times (Table 2). 
Table 2.  Screening of aldehydes 61-67 in the MgBr2·OEt2 mediated aldol reaction with S-phenyl 
thioacetate 56 
SPh
O
1.2 equiv aldehyde, 
1.4 equiv MgBr2
.OEt2,
R SPh
OH O
2.0 equiv i-Pr2NEt, 
CH2Cl2 (0.2 M)
1 equiv
56  
Entry Aldehyde Time (min) Isolated yield (%) 
1 PhCHO (54) 30 96 
2 CHO
MeO  
61 
30 97 
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3 CHO
OMe  
62 
30 96 
4 CHO
O2N  
63 
60 94 
5 CHOCl
 
64 
60 95 
6 CHOPh  
65 
60 92 
7 CHO
 
66 
60 94 
8 CHO
 
67 
60 82 
 
The reversibility of the reaction was explored by combining β-hydroxythioester, N,N-
diisopropylamine, and a competing thioester.  This experiment resulted in a 1:1 mixture of both 
β-hydroxythioster products, suggesting that the aldol addition is reversible under the reaction 
conditions (Scheme 22).13 
SPh
OOH
OMe
AcS
+
1.4 equiv 
MgBr2
.OEt2 SPh
OOH
+ S
OOH
OMe
1 : 161 68 68 69
2.0 equiv 
i-Pr2NEt
 
Scheme 22.  MgBr2·OEt2 mediated reaction between 61 and 68 to determine the reversibility of 
the reaction. 
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The soft enolization methodology can be applied to the formation of 1,3-diketones.  
Reaction of acetophenone (70) with benzoyl chloride (71) in the presence of MgBr2·OEt2 and i-
Pr2NEt generated the β-diketone in good yield after 1 hour (Table 3).
15  3,3-Dimethylbutanoyl 
chloride  (72) similarly generated the corresponding 1,3-diketone, albeit in lower yield.  When 
pentanoyl chloride (73) was used, the 1,3-diketone was produced in low yield (30%) along with 
formation of the bis-acylated product (Table 3).15  
Table 3.  Screening of benzoyl chlorides 71-73 on β-diketone formation 
+
R Cl
O
Ph
O
MgBr2
.OEt2,
i-Pr2NEt, CH2Cl2
R Ph
O O
70  
Entry R Isolated yield (%) 
1 Ph (71) 83 
2 CH2t-Bu (72) 65 
3 Bu (73) 30 
 
A study of the acylating agent revealed that ameliorated yields and reaction times were 
obtained with pentaflurophenyl ester (76) and N-acylbenzotriazoles (77) resulting in greater 
than 90% yields with short reaction times (Table 4).15  These acylating agents are less sensitive 
to water than the acid chlorides, so the reaction could be performed open to the air in 
untreated, reagent grade CH2Cl2 with no change in yield.  The nucleophilic acylation catalyst 
DMAP did not improve the reaction in terms of time or yield (Table 4).15 
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Table 4.  Screening of acylating agents 72-77 on β-diketone formation with acetophenone 70 
+
X
O
Ph
O
MgBr2
.OEt2,
i-Pr2NEt, CH2Cl2
Ph
O O
70  
Entry Acylating agent 
X 
Nucleophilic 
acylation catalyst 
Time (h) Isolated yield (%) 
1 Cl (72)  1 63 
2 Cl (72) DMAP 1 65 
3 O-succinimide (74)   NR 
4 SC6H4-4-NO2 (75)  24 40 
5 SC6H4-4-NO2 (75) DMAP 24 39 
6 OC6F5 (76)  12 79 
7 OC6F5 (76) DMAP 12 80 
8 OC6F5 (76)  24 92 
9 benzotriazole (77)  3 96 
10 benzotriazole (77) DMAP 3 92 
 
Differently substituted pentafluorophenyl esters and N-acylbenzotraizoles acylating 
agents could be employed to generate the corresponding 1,3-diketone.  N-Acylbenzotriazoles 
performed better than the pentafluorophenyl esters in most cases, resulting in high yields and 
low reaction times (Table 5).  This study also demonstrated that the reaction conditions did not 
induce epimerization of a stereocentre α to a carbonyl (Table 5, Entries 7 and 8).15   
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Table 5.  Effect of acylating agent on formation of β-diketone with acetophenone 70 
+
R X
O
Ph
O
MgBr2
.OEt2,
i-Pr2NEt, CH2Cl2
R Ph
O O
70  
Entry X R 1,3-
diketone 
Time (h) Isolated yield 
(%) 
1 Bt CH2t-Bu (77)  2.5 96 
2 O-Pfp CH2t-Bu (76)  24 92 
3 Bt t-Bu (78)  4 99 
4 O-Pfp t-Bu (79)  24 81 
5 Bt Ph (80)  2.5 95 
6 O-Pfp Ph (81)  24 87 
7 Bt TBSO
Ph  (82) 
 4 91 
8 O-Pfp  24 86 
9 Bt Bu (83)  2.5 79 
10 O-Pfp Bu (84)  24 61 
11 O-Pfp 
BocHN Bn  (85) 
 24 73 
12 Bt CH2CH2CHCH2 
(86) 
 3 70 
13 O-Pfp CH2CH2CHCH2 
(87) 
 24 53 
14 Bt (E)-CHCHPh (88)  2.5 81 
 
Coltart explored the scope of the reaction with respect to the ketone.  All reported 
ketones generated the corresponding product in yields of 50% or greater.  Interesting, 1-[(E)]-
cinnamoyl]-1H-benzotriazole 88 and 3-pentanone 97 coupled without further cyclization to the 
19 
 
1,3-cyclohexanedione 98 (Table 6, entry 18 and Figure 1).15  Other Lewis acids explored include 
ZnCl2, CuOTf2, and NiI2 with solvents CH2Cl2, THF, and toluene but no improvement in the 
reaction was found (Table 7).16 
Table 6.  Reaction scope on the MgBr2·OEt2 promoted formation of β-diketones
 
+
R X
O
R2
O
MgBr2
.OEt2,
i-Pr2NEt, CH2Cl2
R R2
O O
R1 R1  
Entry R X R1 R2 Time (h) Isolated yield 
(%) 
1 CH2t-Bu Bt (77) H 2-OMe-C6H4 
(89) 
2.5 92 
2 CH2t-Bu O-Pfp (76) H 2-OMe-C6H4 
(89) 
24 68 
3 CH2t-Bu Bt (77) H 4-OMe-C6H4 
(90) 
4 99 
4 CH2t-Bu O-Pfp (76) H 4-OMe-C6H4 
(90) 
24 99 
5 CH2t-Bu Bt (77) H 2-furanyl 
(91) 
2.5 91 
6 CH2t-Bu O-Pfp (76) H 2-furanyl 
(91) 
24 72 
7 CH2t-Bu Bt (77) Me Ph (92) 4 92 
8 CH2t-Bu O-Pfp (76) Me Ph (92) 24 65 
9 CH2t-Bu Bt (77) OTBS Ph (93) 2.5 65 
10 CH2t-Bu O-Pfp (76) OTBS Ph (93) 24 68 
11 CH2t-Bu Bt (77) H 2-OH-C6H4 
(94) 
24 50 
12 CH2t-Bu O-Pfp (76) H 2-OH-C6H4 
(94) 
24 65 
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13 CH2t-Bu Bt (77) 
 (95) 
3 99 
14 CH2t-Bu O-Pfp (76) 24 58 
15 CH2t-Bu Bt (77) 
(95) 
3 66 
16 CH2t-Bu O-Pfp (76) 24 62 
17 Ph Bt (80) Me (E)-CHCHPH 
(96) 
3 81 
18 (E)-CHCHPh Bt (88) Me Et (97) 16 72 
 
Ph
O
O
98  
Figure 1.  Undetected cyclized 1,3-cyclohexanedione 98 from the coupling of 1-[(E)]-cinnamoyl]-
1H-benzotriazole 88 and 3-pentanone 97 
Table 7.  Screening of Lewis acid on β-diketone formation 
+
Bt
O
Ph
O
Lewis acid,
i-Pr2NEt, solvent
18 h Ph
O O
9977 70  
Entry Lewis acid Solvent Conversion (%) 
1 MgBr2·OEt2 CH2Cl2 96 
2 MgBr2·OEt2 THF 94 
3 MgBr2·OEt2 toluene 82 
4 ZnCl2 CH2Cl2 61 
5 ZnCl2 THF trace 
6 ZnCl2 toluene 9 
7 Cu(OTf)2 CH2Cl2 trace 
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8 Cu(OTf)2 THF trace 
9 Cu(OTf)2 toluene trace 
10 NiI2 CH2Cl2 NR 
11 NiI2 THF NR 
12 NiI2 toluene NR 
 
Coltart and co-workers have studied a four-component cascade aldol addition of 
thioester enolates with enolizable aldehydes (Scheme 23).17 In one pot, an anti-selective aldol 
addition from 2 equivalents of a thiolate, one equivalent of an αβ-unsaturated acid chloride 
and one equivalent of an aldehyde is possible.  The reaction proceeds via acyl transfer of the 
thiolate onto the αβ -unsaturated acid chloride (Scheme 23).  The second equivalent of thiolate 
can add via 1,4-addition to the αβ-unsaturated thioester.  This process generates a thioester 
enolate which can undergo an aldol reaction with an aldehyde (Error! Reference source not 
found.). 
Cl
O
+ RSLi SR
O
-LiCl
RSLi
SR
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RS
SR
O
RS
R1
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100 101 102 103  
Scheme 23.  Four component cascade reaction: formation of thioester enolate followed by 
aldol addition to the aldehyde. 
The four component aldol addition was attempted with MgBr2·OEt2, PhSLi (104) and 
acryloyl chloride (100) (Table 8).  Within 30 minutes, the reaction had reached completion and 
gave the desired product in 67% yield with a high anti: syn ratio of 13:1 in favour of the anti 
diastereomer.  The yield could be improved to 88% by employing 1.2 equivalents of MgBr2·OEt2, 
3 equivalents of PhSLi (104), and 1.5 equivalents of acryloyl chloride (100).  No aldol product 
was observed in the absence of MgBr2·OEt2.  Other aldehyde acceptors were investigated and 
all generated the aldol addition products in high yields and high diastereoselectivity in favour of 
the anti diastereomer (Table 8).17 
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Table 8.  Screening of aldehydes 54, 67, 105-108 in the MgBr2·OEt2 mediated four component 
aldol addition with acryloyl chloride 100 
Cl
O
+ RCHO
PhSLi (104),
MgBr2
.OEt2,
CH2Cl2 (untreated),
open to air, 30 min
R Ph
OOH
SPh100  
Entry R= Yield (%) Anti:Syn 
Diastereoselectivity 
1 -Ph (54) 88 13:1 
2 -(CH2)2CH3 (105) 71 11:1 
3 -(CH2)6CH3 (106) 68 16:1 
4 -(CH2)2Ph (107) 71 14:1 
5 -C6H11 (67) 81 >20:1 
6 -CH(CH3)2 (108) 76 >20:1 
 
The scope of the reaction could be expanded to include other acrylate reagents.  
Oxoesters as well as N-phenyl amide showed low diastereoselectivity in favour of the anti 
diastereomer.  In addition, the other thioesters investigated showed diminished 
diastereoselectivity to as low as 1.5:1 (S-tert-butyl thioester (110), Entry 4, Table 9).17 
Table 9.  Screening of acrylate reagents 109-115 in the MgBr2·OEt2-mediated four component 
aldol addition with cyclohexanal 67 
R
O
+
PhSLi (104),
MgBr2
.OEt2,
CH2Cl2 (untreated),
open to air, 30 min
R
OOH
SPh
O
67  
Entry R= Yield (%) anti-syn 
Diastereoselectivity 
1 -SPh (109) 79 >20:1 
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2 -SC6H3-2,6-Me (110) 60 11:1 
3 -SEt (111) 82 4:1 
4 -St-Bu (112) 77 1.5:1 
5 -OPh (113) 72 2:1 
6 -Ot-Bu (114) 78 1:1 
7 -NHPh (115) 64 2:1 
 
The soft enolization methodology was applied to a direct crossed-Claisen coupling of 
thioesters by Coltart et al.  When N-acylbenzotriazole and thioesters were reacted under soft 
enolization conditions (MgBr2·OEt2 and i-Pr2NEt), the desired β-diketones were isolated in high 
yields (Table 10).18  Both reagents have an -proton able to undergo deprotonation to form the 
enolate anion.  However, no self-addition products or the other crossed-Claisen products were 
detected.  Oxoesters did not perform as well as thioesters (entry 1 versus entry 2) and aliphatic 
thioesters were lower yielding than aromatic thioesters.18  
Table 10.  MgBr2·OEt2 and i-Pr2NEt promoted Crossed-Claisen with benzotriazole 54 and 
thio/oxo-esters 
R
O
+
MgBr2
.OEt2
i-Pr2NEt
CH2Cl2 R
OO
Bt
O
77  
Entry R= Time (h) Yield (%) 
1 -SPh (32) 4 93 
2 -OPh (139) 26 44 
3 -SEt (140) 4 83 
4 -SBn (55) 4 80 
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The scope of the crossed-Claisen coupling via soft enolization was explored by varying 
the thioester component and the N-acylbenzotriazole component (Table 11).  The reaction 
could be performed on reactants with varying functional groups including ester, acetal, alkenes 
and αβ-unsaturated carbonyl compounds.  The β-keto-thioesters produced from these 
reactions can directly be made into β-keto thioesters, amides and β-diketones.18 
Table 11.  Scope of MgBr2·OEt2 and i-Pr2EtN mediated crossed-Claisen reaction 
R Bt
O
+
MgBr2
.OEt2
i-Pr2NEt
CH2Cl2
R SPh
OO
R1
SPh
R1
O
 
Entry R R1 Yield (%) 
1 -CH2t-Bu (77) -Me (134) 87 
2 -CH2t-Bu (77) -CH2CH2CH3 (141) 85 
3 -CH2t-Bu (77) -CH2Ph (142) 88 
4 -CH2t-Bu (77) -OBn (143) 78 
5 -Ph (80) -Me (134) 91 
6 -i-Pr (144) -Me (134) 91 
7 -(E)-CHCHPh (88) -Me (134) 76 
8 -C6H11 (145) -Me (134) 90 
9 TBSO
Ph (82) 
-Me (134) 64 
10 -o-(CO2Me)-Ph (146) -Me (134) 87 
11 -o-(CO2Me)-Ph (146) 
(147) 
92 
12 -o-(CO2Me)-Ph (146) 
O
O
(148) 
80 
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The crossed Claisen coupling with MgBr2·OEt2 and i-Pr2NEt was applied to the total 
synthesis of LY294002 (149).  It is a potent, specific inhibitor of PI3-K which is involved in many 
diseases including diabetes, cancer, and chronic inflammation.18  The key step in the synthesis 
was a direct crossed-Claisen coupling to demonstrate the utility of the soft enolization 
methodology (Scheme 24).18  This methodology accessed LY294002 (149) in 7 steps and 67% 
overall yield, thus demonstrating the usefulness of the direct crossed-Claisen coupling with 
MgBr2·OEt2 and i-Pr2NEt. 
O N
O
OPh
149
OH
O
Ph
N
O
O
OH
O
Ph
SPh
O
OH
O
Ph
SPh
O
Bt
+
150 151 152 56  
Scheme 24.  MgBr2·OEt2 promoted direct crossed-Claisen coupling towards the synthesis of 
LY294002 (149). 
The scope of the soft enolization methodology has been expanded from aldol additions 
with thioesters to cascade reactions, Mannich additions and Claisen condensations for simple 
systems by Coltart.  Herein, we have applied the soft enolization methodology to the TR2P.  The 
Results and Discussion chapter will discuss the highly diastereoselective direct aldol reactions of 
thiopyran substrates (16 and 17 with 15) via soft enolization. 
 
1.3. Research Objective 
 The current synthetic route for the preparation of enantiopure non-Felkin 
tetrapropionate synthons is a limitation of the TR2P.  Enantiopure tetrapropionate synthons 17-
AS and 17-SS resulting from Felkin addition of 16 to 15 are directly accessible using the 
organocatalyst (S)-5-(pyrrolidin-2-yl)tetrazole 48.  However, non-racemic first aldol adducts 17-
AA and 17-SA from non-Felkin addition are made via enantiopure aldehyde 15.  A more direct 
approach to enantioenriched 17-AA and 17-SA is required.  The goal of the this research was to 
develop a methodology using chiral transition metal-based Lewis acids and/or chiral 
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organocatalysts with chelating Lewis acids to access non-racemic non-Felkin first aldol adducts.  
This methodology could then be extended to access new hexapropionate synthons by non-
Felkin addition of 17-AA or 17-SA to 15. 
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2. RESULTS AND DISCUSSION 
2.1. Transition metal catalysis – Bis(oxazoline) ligands 
Chiral C2-symmetric bis(oxazoline) (BOX) ligands are an important ligand class for 
asymmetric catalysis.19-25  They are used to prepare catalysts for various enantioselective 
reactions, including inter- and intramolecular cyclopropanations, aziridinations, Michael 
additions, Mukaiyama-Michael reactions, allylic substitution reactions, radical reactions, Diels-
Alder reactions, hetero Diels-Alder reactions, 1,3-dipolar cycloaddition reactions, ene and 
hetero ene reactions, as well as Mukaiyama aldol reactions.20  BOX ligands have been 
successfully used for many applications due to the readily tuneable nature of the ligand 
structure (Figure 2).  The R groups, counter-anion and metal centre are all easily adjustable.  
BOX ligands are a good choice for enantioselective catalysis due to the rigidity of the ligand and 
the resulting close proximity of the two substituents to the coordination site of the metal 
centre.21   
BOX ligands are attractive due to their easy synthesis from readily available amino 
alcohols.  Synthesis of the C2-ligand 154 is a one step procedure starting from the amino alcohol 
(Figure 2).22  The catalyst can be prepared by reacting the ligand with an equimolar quantity of a 
metal salt.  The choice of R group, counter-anion, and metal can be altered to modify the rate 
and selectivity of a particular reaction. 
NC CN
2
NH2
R
R'
HO
N N
OO
R'R R' R
MX2
N N
OO
R'R R' R
M
XX
Zn(OTf)2
154 155153152  
Figure 2. Synthesis of BOX metal complex from 2,2-dimethylmalononitrile 152 and β-amino 
alcohol 153. 
Non-symmetric BOX ligands can be synthesized in a similar manner, constructing one 
oxazoline ring at a time (Figure 3).  The first oxazoline ring is formed using Zn(OAc)2 as catalyst 
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and the second oxazoline ring is formed in a subsequent step using Zn(OTf)2.
23  The resulting 
BOX-metal complex contains sterically different but electronically equivalent coordination 
points for the incoming reactant to coordinate to.  Thus, the selectivity of the reaction can be 
further manipulated. 
NC CN
NH2
R
R'
HO
N
CNO
R
R'
MX2
N N
OO
R''
R
R'
R'''
M
XX
Zn(OAc)2
N N
OO
R''R R' R'''
Zn(OTf)2
NH2
R'''
R''
HO
157 158156153152 153  
Figure 3.  Synthesis of non-symmetric bis(oxazoline) complex 158 from 2,2-
dimethylmalonylnitrile 152 and two different -amino alcohols 153. 
 The Lewis acidity of the BOX-metal complex can be tuned by varying the counter ion.  
For example the triflate (-OTf) is weakly bound to the metal centre while hexafluoroantimonate 
(SbF6-) counter ions are fully dissociated from the metal centre.  Thus, the SbF6-counter ions 
make the complex more Lewis acidic than the -OTf counterpart.  Complexes with SbF6-
counterions are made via anion exchange from the corresponding chlorides by treatment with 
2 equivalents of AgSbF6 and removal of the AgCl by-product through filtration (Figure 4).  
N N
OO
R''R
R' R'''
M
ClCl
159
2 AgSbF6
N N
OO
R''R R' R'''
M
160
2+
2 SbF6
-
-2 AgCl
 
Figure 4.  Formation of SbF6-BOX complex from the corresponding chloride salt. 
Copper(II) bis(oxazoline) (BOX) catalysts 155 (Figure 2) and copper(II) 
bis(oxazolinyl)pyridine (PYBOX) catalysts are active Lewis acid catalysts first reported in 1991 by 
Evans24 and, Corey.25  Evans and coworkers have shown that these chiral Lewis acids are 
effective catalysts for the Mukaiyama aldol reaction with aldehyde substrates that are capable 
of chelation.  Evans and coworkers reported a catalytic enantioselective aldol addition of 
enolsilanes to (benzyloxy)acetaldehyde catalyzed by C2-symmetric copper(II) BOX and PYBOX 
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complexes.19  Bis(oxazoline) and bis(oxazolinyl)pyridine ligands were screened for the aldol 
addition of 162 to (benzyloxy)acetaldehyde 161 (Table 12 and Table 13).  Complex 173 was 
found to be the optimal catalyst and was the catalyst chosen to explore other reaction 
parameters.   
Table 12.  Screening of BOX catalysts 164-168 in the Mukaiyama aldol reaction of 161 with 162 
N N
OO
R R
Cu
XX
10 mol%, CH2Cl2
2. 1 N HCl/THFH
BnO
O
+
StBu
OTMS
StBu
BnO
O
161 162
1.
163
OH
(R)
 
Entry R X Time (-78 °C) ee (%) a 
1 Ph OTf (164) 15 min 9 (R) 
2 CHMe2 OTf (165) 15 min 9 (S) 
3 Bn OTf (166) 60 min 88 (R) 
4 CMe3 OTf (167) 60 min 91 (R) 
5 CMe3 SbF6 (168) 15 min ≤64 (S) 
a Enantiomeric excess determined by HPLC using a Chiralcel OD-H column.  Absolute 
configuration determined by comparison of the optical rotation to literature values. 
Table 13.  Screening of PYBOX catalysts 169-173 in the Mukaiyama aldol reaction of 161 with 
162 
Cu
10 mol%, CH2Cl2
2. 1 N HCl/THFH
BnO
O
+
StBu
OTMS
StBu
BnO
O
161 162
1.
163
OH
(S)
N
N
OO
N
RR
2+
2 X-
 
Entry R X Time (T °C) ee (%) a 
30 
 
1 CMe3 SbF6 (169) 12 h (-78) 62 
2 CHMe2 SbF6 (170) 15 min (-78) 85 
3 Bn SbF6 (171) 15 min (-78) 67 
4 Ph OTf (172) 60 min (-78) 96 
5 Ph SbF6 (173) 15 min (-78) 99 
6 Ph SbF6 (173) -50 
b 87 
7 Ph SbF6 (173) -20 
b 82 
8 Ph SbF6 (173) 0 
b 78 
a Enantiomeric excess determined by HPLC using a Chiralcel OD-H column.  Absolute 
configuration determined by comparison of the optical rotation to literature values. b Time for 
complete reaction was not determined in temperature profile study. 
Evans and coworkers examined the effect of aldehyde chelation.  Complex 173 was 
found to catalyze the reaction of (benzyloxy)acetaldehyde 161 with silylketene acetal 162 to 
afford 163 in high enantioselectivity.  However, the same catalyst yields a less enantioselective 
process with an aldehyde that is a weaker chelator.  For example, aldehyde 174 yielded a 
product with significantly reduced ee (Entry 2, Table 14).  Further, catalyst 173 yields nearly 
racemic product when an aldehyde totally incapable of chelation (175) is used (Entry 2, Table 
14).19  
Cu
10 mol%, CH2Cl2
2. 1 N HCl/THFH
X
O
+
StBu
OTMS
StBu
X
O
162
1.
OH
N
N
OO
N
PhPh
2+
2 SbF6
-
173
 
Table 14.  Scope of aldehyde to determine requirement for aldehyde chelation 
Entry X ee (%) 
1 OBn (161) 99 
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2 OTBS (174) 56 
3 CH2Ph (175) <10 
 
In order to achieve good levels of enantioselectivity, the substrate must be able to 
chelate to the metal centre.  Racemic products are obtained when substrates incapable of 
chelation are employed.19  Aldehyde 15 is capable of chelation and further, chelating conditions 
favour high non-Felkin selectivity.7  Thus, the use of Lewis acid catalysts incorporating BOX-type 
ligands to promote the aldol reaction of 25 with 15 might be suitable for the preparation of 
non-racemic C1’-C6’’ anti (or non-Felkin) products. 
Whether the BOX-complexes could catalyze an aldol reaction between 15 and 25 was 
investigated.  Initially, achiral BOX complexes 176 were explored to determine whether the BOX 
chemistry could be applied to the TR2P.  Unfortunately, BOX complexes prepared from 
copper(II) chloride or copper(II) triflate, were unable to catalyze any aldol reaction between 15 
and 25.  Various Lewis acidic transition metal salts without additional ligands including copper 
chloride, copper triflate, magnesium triflate, magnesium perchlorate, zinc triflate, scandium 
triflate and hafnium triflate were also tested but none could catalyze the aldol reaction 
between 15 and 25.  This could arise because aldehyde 15 is less electrophilic than 
(benzyloxy)acetaldehyde 161 which bears an electronegative oxygen atom in the α-position.  
Additionally, silyl enol ether 25 is much less nucleophilic due to electronic (no sulfur) and steric 
reasons.  Because adding a chelating ligand on the metal centre would reduce the Lewis acidity, 
further investigations into BOX systems were abandoned. 
S
H
O
OO
S
OTMS
S S
OO
OOH
N N
OO
M
XX
176
15 25 17  
Scheme 25.  Application of BOX chemistry to TR2P. 
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2.2. Organocatalysis – Modification of (S)-5-(pyrrolidin-2-
yl)tetrazole catalyzed reaction 
 
Drawing from prior work in the Ward group, reacting aldehyde 15 with ketone 16 in the 
presence of catalyst 48 produces 17-AS in high yield (75%) and high enantiopurity (>98% ee) on 
multigram scale (Scheme 19).9  A minor amount of 17-AA is formed in the reaction (17-AS:17-
AA ca 25:1) and its enantiomeric excess was determined to be 95%.  Because the minor 
diastereomer was formed with such high enantiomeric excess, attempts were made to switch 
the diastereoselectivity of this reaction to favour 17-AA.  The hypothesis was that in the 
presence of a chelating Lewis acid the aldehyde diastereoface selectivity could be modulated, 
leading to the non-Felkin substrates. 
When one equivalent of MgBr2·OEt2 was added, the enantiomeric excess of 17-AA was 
>95% and the diastereomeric ratio was reduced from 25:1 to 12:1 of 17-AS and 17-AA, 
respectively (Table 15, Entry 1).  Using excess aldehyde and three equivalents of MgBr2·OEt2 
yielded approximately the same diastereomer ratio.  However, using 6 equivalents of 
MgBr2·OEt2 further reduced the diastereomer ratio to 7:1 of 17-AS and 17-AA, respectively 
(Table 15, Entries 2 and 3).  
Table 15.  Effect of increasing equivalents of MgBr2·OEt2 on the (S)-5-(pyrrolidin-2-yl)tetrazole 
48 catalyzed reaction of 15 and 16. 
N
H HN N
N
N
S
H
O
OO
S
O
20-mol %
SS
O O
O HO
15 (2 equiv) 16 (1 equiv)
48
17-AS
1' 6"
MgBr2
.OEt2, DMSO
SS
O O
O HO
1' 6"
17-AA
6 d, rt
 
Entry Equiv 
MgBr2·OEt2 
Conc. (M) Yield (%) Diastereoselectivity 
1 a 1 1.1 33 17-AS (12) : 17-AA (1) b 
2 3 0.4 24 17-AS (13) : 17-AA (1) 
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3 6 0.2 31 17-AS (7) : 17-AA (1) 
a 1 equiv of 15; reaction time 4 days.  b 17-AA was formed with >95% ee. 
The effect of water as an additive was probed.  Adding 1 equivalent of water to the 
reaction improved the ratio to 9:1 of 17-AS and 17-AA, respectively (Table 16, Entry 3).   
Table 16.  Effect of adding MgBr2·OEt2 to (S)-5-(pyrrolidin-2-yl)tetrazole (48) catalyzed reaction 
of 15 and 16. 
N
H HN N
N
N
S
H
O
OO
S
O
20-mol %
SS
O O
O HO
15 (1 equiv) 16 (2 equiv)
48
17-AS
1' 6"
MgBr2
.OEt2,DMSO, rt
SS
O O
O HO
1' 6"
17-AA  
Entry Equiv 
MgBr2·OEt2 
Conc. (M) c Time 
(d) 
Yield (%) Diastereoselectivity 
17-AA : 17-SA : 17-AS : 
17-SS 
ee (%) d 
1 a, b 0 9 8 75 1 : 0 : 25 : 0 >98 (17-AS), 
>95 (17-AA) 
d 
2 3 0.4 6 40 1 : 0 : 13 : 0  
3 b 3 0.4 3 20 e 1 : 0 : 9 : 0  
a Literature result. b Equiv H2O = 1.04. 
c With respect to aldehyde. d Determined by HPLC on a 
chiral stationary phase. e Conversion as determined by 1H NMR. 
The effects of concentration and stoichiometry of MgBr2·OEt2 were also examined.  
Lowering the concentration resulted in reduced yield and gave inferior diastereoselectivity 
(Table 17). 
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Table 17.  Effect of concentration on adding MgBr2·OEt2 to the (S)-5-(pyrrolidin-2-yl)tetrazole 
(48) catalyzed aldol reaction of 15 and 16. 
N
H HN N
N
N
S
H
O
OO
S
O
20-mol %
SS
O O
O HO
15 (1 equiv) 16 (1 equiv)
48
17-AS
1' 6"
3 d, MgBr2
.OEt2
DMSO, rt SS
O O
O HO
1' 6"
17-AA  
Entry Equiv 
MgBr2·OEt2 
Conc. (M) a Yield (%) Diastereoselectivity 
17-AA : 17-SA : 17-AS : 17-SS 
1 1 0.9 44 1 : 0 : 11 : 0 
2 2 0.6 40 1 : 0 : 14 : 0 
3 3 0.5 28 1 : 0 : 16 : 0 
a With respect to aldehyde 15. 
It is important to note that the (S)-5-(pyrrolidin-2-yl)tetrazole (48)-catalyzed reaction to 
produce enantioenriched 17-AS  is conducted at very high concentration and becomes a thick 
oil and eventually solidifies over the course of the reaction.  The high concentration is necessary 
to keep reaction times reasonably low.  At such high concentrations, effective mixing of 
MgBr2·OEt2 may be problematic.  Stirring efficiency may have contributed to the variable yields 
and diastereoselectivities observed. 
After further optimization efforts, the diastereoselectivity of the reaction of 15 with 16 
catalyzed by 48 could not be improved to make the 17-AA as the major adduct formed.  Even in 
the presence of excess MgBr2·OEt2, the generation of 17-AS is greatly favoured over 17-AA.  A 
dramatic reversal in the diastereoselectivity of the reaction with catalyst 48 would be required 
to make the reaction synthetically useful for the preparation of 17-AA.  Optimizing the reaction 
by altering concentration, stoichiometry, additives, etc was not deemed promising to produce 
synthetically useful amounts of 17-AA. 
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2.3. Organocatalysis – trans-N,N-dialkylated 
diaminocyclohexane catalyst 
 
As the combination of MgBr2·OEt2 in conjunction with 48 became less promising, 
alternative organocatalysts were considered.  Luo and co-workers have reported the primary-
tertiary-trans-diamine-Bronsted acid catalyst 179 for enantioselective aldol reactions of cyclic 
and acyclic ketones with aromatic aldehydes.26  This novel organocatalyst exhibits high 
diastereoselectivity and enantioselectivity with a range of substrates, including the difficult 
aliphatic ketone substrates.  A second acidic additive improved the catalysis, presumably by 
facilitating the enamine catalytic cycle.  Remarkably, the primary-tertiary-trans-diamine catalyst 
179 could provide syn selectivity with aliphatic ketones, a phenomenon not previously reported 
for organocatalysts.  Cyclic ketones, only capable of forming E-enamines, produce anti aldol 
diastereoselectivity while the syn selectivity comes from the Z-enamines of the aliphatic 
ketones (Figure 5). 
HN
O
H
177 178
N
Pr
H
Pr
HN
R'
H
O
H
N
Pr
H
Pr
(A) (B)
S
OO
S
OOR
N
NH2
179  
Figure 5.  Proposed transition state for aldol reactions catalyzed by trans-N,N-dialkylated 
diaminocyclohexane catalyst 179 with (A) linear ketones 177 and (B) cyclic ketones 
178.  
 The primary-tertiary-trans-diamine catalyst 179 was appealing for the TR2P for several 
reasons.  Primarily, it was hypothesized that the novel syn-enamine transition state proposed 
for this catalyst may produce non-Felkin adducts from 15 by simultaneous hydrogen bonding to 
the aldehyde carbonyl and the ketal.  Secondly, the syn and anti aldol topicity could be 
exploited by using thiopyranone 16 to generate the anti adducts, while employing the linear 
ketone 5-pentanone 180 to generate syn adducts (Figure 6).  The product 181 is viewed as a 
mono-desulfurized analogue of 17-SA.  In this way, the change in diastereoselectivity 
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characteristic of catalyst 179 for linear versus cyclic ketones might be exploited within the 
TR2P. 
S
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O
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O
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N
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Figure 6.    Proposed application of catalyst 179 to generate 17-AA and the 17-SA analogue 181. 
Catalyst 179 was prepared and applied to the aldol reaction of 15 with 16.  Under 
several conditions, the reaction was sluggish, producing low amounts of products.  Employing 
the optimized conditions according to Luo,26 10% conversion to 17-AS was observed after 7 
days in all five solvents tested (Table 18).  To increase the amount of non-Felkin products (17-
SA, 17-AA), the effect of adding MgBr2·OEt2 to this reaction was tested.  When the amount of 
MgBr2
·OEt2 was increased to three equivalents, 30% conversion to a mixture of three of the 
four aldol diastereomers could be detected (Table 19, entry 1).  This result was promising as the 
non-Felkin/Felkin ratio2 was 3:1.  Varying the acid co-catalyst changed the diastereoselectivity 
while the conversion remained low (Table 19).  Using 3 equivalents of MgBr2
·OEt2, the reaction 
proceeded better with trifluoromethanesulfonic acid as co-catalyst and produced non-Felkin 
products exclusively.  Unfortunately, under all conditions tested, the conversion and the 
enantioselectivity remained low. 
                                                          
2
 Ratio of (17-AA+17-SA):(17-AS+17-SS).  Higher ratio indicates non-Felkin adducts predominate over Felkin 
adducts. 
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Table 18.  Effect of solvent on the aldol reaction of 15 and 16 catalyzed by 179 
S
H
O
OO
S
O5 equiv
10-mol %
S S
OO
OOH
N
NH2
.TfOH
10% p-nitro-benzoic acid
7 d
15 16 17-AS
179
 
Entry Solvent Conversion (%) a 
1 DMSO/H2O ~10 
2 DMSO ~10 
3 CH2Cl2 ~10 
4 Toluene ~10 
5 Methanol ~10 
a Conversion from 1H NMR. 
Table 19.  Effect of varying the co-catalyst on the aldol reaction between 15 and 16 catalyzed by 
179 
15 16
S
H
O
OO
S
O5 equiv
25-mol %
S S
OO
OOH
N
NH2
4 d
Dichloromethane (0.1 M)
3 equiv MgBr2
.OEt2
179
17  
Entry Acid  
co-catalyst (equiv) 
Conv  
(%) a 
Diastereoselectivity a 
17-AA : 17-SA : 17-AS : 
17-SS 
ee b 
1 c, d - 30 1 : 0.8 : 0.6 : 0 28% (17-SA) 
2 TfOH (0.25) 20 1 : 0.8 : 0 : 0 11% (17-SA),  
20% (17-AA) 
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3 TFA (0.25) trace -  
4 PTSA.H2O (0.25) ~15 1 : 0.9 : 0 : 0 0% (17-SA) 
a Determined by 1H NMR of the crude reaction mixture. b Determined by chiral HPLC. c 10 equiv 
thiopyranone 16. d 0.5 equiv catalyst 179. 
Although it was demonstrated that the diastereoselectivity of the first aldol reaction of 
the TR2P could be tuned in favour of non-Felkin products by addition of the chelating Lewis acid 
MgBr2
·OEt2, initial optimization attempts still resulted in low conversion and low enantiomeric 
excess.  Varying the solvents from dichloromethane to toluene, methanol or dimethylsulfoxide 
resulted in low conversion to products.  To account for the low enantiomeric excess and the 
low conversion it was hypothesized that the catalyst was simply acting as a base and 
deprotonating ketone 16 to form the magnesium enolate.  To test this hypothesis, N,N-
diisopropyl amine was chosen as the base due to its similarity to the tertiary amine portion of 
primary-tertiary trans-diamine catalyst 179.  Under similar conditions to those employed using 
179, 19% conversion (based on aldehyde) was obtained with three of the four diastereomers 
detected (Figure 7).  This supports the notion that the tertiary-diamine portion of 179 was 
acting as a base to deprotonate the -proton of 16, suggesting that the magnesium enolate, 
not the enamine, was responsible for the conversion to products.  The use of a weak base in 
combination with a Lewis acid had been explored by the Coltart group to mediate an aldol 
addition of thioesters and the results of this research was summarized in Chapter 1.  
15 16
S
H
O
OO
S
O5 equiv
S S
OO
OOH
19% conversion by 1H NMR
of the crude reaction mixture
CH2Cl2 (0.3 M), 3 h
3 equiv MgBr2
.OEt2
17
0.5 equiv i-Pr2NEt
17-AA : 17-SA : 17-AS : 17-SS
33 : 43 : 24 : 0
Non-Felkin:Felkin ratio
3.2:1.0
 
Figure 7.  The effect of base on the MgBr2
·OEt2 promoted aldol reaction between 15 and 16. 
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2.4. Aldol Reactions using Soft Enolization – Mono aldol 
formation 
After further exploration of the aldol addition of 15 and 16, it was determined that 
conversion with respect to the aldehyde did not accurately represent the yield of aldol adducts 
obtained.  Thus, the starting aldehyde 15 and thiopyranone 16 were independently subjected 
to the reaction conditions to test the stability of these reagents over the course of the reaction.  
Within ten minutes, both aldehyde 15 and thiopyranone 16 had undergone reaction.  Aldehyde 
15 slowly decomposed under these conditions and several side products could be observed 
although none were identified.  Under the same reaction conditions and in the absence of 
aldehyde 15, thiopyranone 16 underwent a self-aldol condensation (Figure 8). 
2 equiv MgBr2
.OEt2
S
O
0.3 M CH2Cl2, 10 mins
1 equiv i-Pr2NEt
S
O S
91% isolated yield
16 182
OH
 
Figure 8.  Self-aldol condensation of thiopyranone 16. 
 To determine if the thiopyranone dimer 182 was formed reversibly, it was subjected to 
reaction with thiopyran aldehyde 15 under the same conditions.  Aldol adducts 17 were 
obtained with yields and diastereoselectivites similar to those using 16.  Thus, the formation of 
the thiopyranone dimer 182 is reversible under the reaction conditions so there is no need to 
suppress its formation (Figure 9). 
6 equiv MgBr2
.OEt2
S
0.3 M CH2Cl2
1 equiv i-Pr2NEt
OO
H
O
S
O S
+
S S
OO
OOH
Non-Felkin/Felkin ratio: 8/1
30% yield via 
internal standard
15 (2 equiv)125 17
OH
 
Figure 9.  Determination of reversibility of thiopyranone-dimer 182. 
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 The stability of the aldol adducts was also examined.  17-SA and 17-AS were 
independently subjected to 1 equivalent of i-Pr2NEt and 3 equivalents of MgBr2
·OEt2 in CH2Cl2 
for 2.5 hours.  Reaction of 17-SA produced a small amount of 17-AA indicating that a minor 
amount of isomerization had occurred but no products from retro-aldol could be detected 
(Figure 10).  Similarly, reaction of 17-AS gave a small amount of 17-SS but no products from 
retro-aldol (Figure 10). 
S S
OO
OOH
3 equiv MgBr2
.OEt2
0.3 M CH2Cl2
1 equiv i-Pr2NEt
2.5 h
S S
OO
OOH
S S
OO
OOH
+
17-SA 17-SA (1.0) 17-AA (0.061)
S S
OO
OOH
3 equiv MgBr2
.OEt2
0.3 M CH2Cl2
1 equiv i-Pr2NEt
2.5 h
S S
OO
OOH
17-AS 17-AS (1.0)
S S
OO
OOH
+
17-SS (0.047)  
Figure 10.  Stability of 17-SA and 17-AS to the aldol reaction conditions. 
The reaction time was explored by removing aliquots at various time intervals.  After ten 
minutes of reaction time, it was found that all the aldehyde had been consumed and the ratio 
of adducts was 17-AA (53):17-SA (47) with numerous side products.  Another aliquot taken 
after an hour yielded similar results, again no aldehyde 15 present and the ratio of 
diastereomers remained nearly constant at 17-AA (51):17-SA (49) (Figure 11). 
S
0.3 M CH2Cl2, rt
2 equiv i-Pr2NEt
OO
H
O
S
O
S S
OO
OOH
+
6 equiv MgBr2
.OEt2
15 16 (2 equiv) 17
               17-AA : 17-SA
10 mins       53 : 47
60 mins       51 : 49  
Figure 11.  Completion of the MgBr2
·OEt2 promoted aldol addition of 15 and 16 determined by 
a time course study. 
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The order of addition of the reagents was next surveyed.  Adding a solution of 
thiopyranone 16 to a solution of the other reagents drastically reduced the yield (3%) and non-
Felkin/Felkin ratio (0/1) (Table 20, Entry 1).  This could be attributed to the MgBr2·OEt2 and the 
i-Pr2NEt forming a Lewis acid-base adduct leaving no i-Pr2NEt available in solution to form the 
enolate.  Similarly, adding a solution of thiopyranone 16 and i-Pr2NEt to a solution of the other 
reagents also resulted in low yield (13%) and low non-Felkin/Felkin selectivity (3/1) (Table 20, 
Entry 2).  When the i-Pr2NEt was added over a period of 5 minutes to a solution of aldehyde 15, 
thiopyranone 16, and MgBr2·OEt2, the yield was 19% and non-Felkin/Felkin selectivity 7/1 
(Table 20, Entry 3).  When the i-Pr2NEt was added rapidly, a similar yield and 
diastereoselectivity was achieved (Table 20, Entry 4).  Thus, the rate of addition of the i-Pr2NEt 
was determined to be inconsequential and the method of rapid addition was used for all 
subsequent experiments. 
S
0.3 M CH2Cl2
0.5 equiv i-Pr2NEt
OO
H
O
S
O
S S
OO
OOH
+
10 min, rt
3 equiv MgBr2
.OEt2
15 16 (1 equiv) 17  
Table 20.  Determination of the order of addition on the MgBr2
·OEt2 promoted aldol reaction of 
15 and 16. 
Entry Order of 
addition 
Yield (%) b Diastereoselectivity c 
17-AA : 17-SA : 17-AS : 
17-SS 
Non-Felkin/ 
Felkin c 
17-SA : 17-
AA c 
1 16 last over 1 
min 
3 0 : 0 : 0 : 100 0/1 0 : 0 
2 16 and i-Pr2EtN 
last over 5 mins 
13 30 : 45 : 0 : 24 3/1 1.0 : 1.5 
3 i-Pr2EtN last over 
5 mins 
19 35 : 51 : 6 : 7 7/1 1.0 : 1.5 
4 i-Pr2EtN last 24 35 : 54 : 5 : 6 8/1 1.0 : 1.5 
a Reactions conducted on 0.10-mmol scale following the General Procedure for aldol reactions 
of 16 with 15 via Soft Enolization except where noted.  b Determined via internal standard (1,4-
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dicyanobenzene) by 1H NMR of the crude reaction mixture. c Determined by 1H NMR of the 
crude reaction mixture. 
When the amount of MgBr2·OEt2 was increased from 3 to 6 equivalents, there was an 
increase in the non-Felkin/Felkin selectivity (Table 21).  A 6-fold excess of MgBr2·OEt2 with 
respect to aldehyde 15 is enough to achieve high non-Felkin selectivity.  As an additional 
benefit, these experiments demonstrate that this method produces a more favourable 17-
SA:17-AA ratio, allowing more direct access to the thermodynamically less stable 17-AA 
diastereomer (the equilibrium constant is 2:1 in favour of 17-SA over 17-AA8). 
Table 21.  Effect of MgBr2·OEt2 on the diastereoselectivity of the aldol reaction between 15 and 
16 
S
0.3 M CH2Cl2
0.5 equiv i-Pr2NEt
OO
H
O
S
O
S S
OO
OOH
+
10 min, rt
MgBr2
.OEt2
15 16 (1 equiv) 17  
Entry Equiv 
MgBr2·OEt2 
Yield (%) b Diastereoselectivity c 
17-AA : 17-SA : 17-AS : 
17-SS 
Non-Felkin/ 
Felkin c 
17-SA : 17-
AA c 
1 3 17 37 : 55 : 4 : 4 12/1 1.5 : 1.0 
2 6 31 47 : 51 : 2 : 1 45/1 1.1 : 1.0 
a Reactions conducted on 0.10-mmol scale following the General Procedure for aldol reactions 
of 16 with 15 via Soft Enolization except where noted.  b Determined via internal standard (1,4-
dicyanobenzene) by 1H NMR of the crude reaction mixture. c Determined by 1H NMR of the 
crude reaction mixture. 
Lowering the temperature of the reaction from room temperature to 0 oC reduced the 
amount of side products formed without adversely affecting the yield or diastereoselectivity 
(Table 22).  Reaction at -20 oC further reduced the amount of side products but also adversely 
affected the non-Felkin/Felkin selectivity and yield.  At this reduced temperature, less chelated 
aldehyde versus non-chelated aldehyde could be present explaining the increase in Felkin 
products.  Concentration effects were also probed (Table 22).  At lower concentration, the 
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amounts of undesired side products were reduced.  Beneficially, the non-Felkin/Felkin ratio 
increased as concentration decreased. 
Table 22.  Effect of concentration on the diastereoselectivity of MgBr2·OEt2 promoted aldol 
reaction between 15 and 16 
S
CH2Cl2, 10 mins
0.5 equiv i-Pr2NEtOO
H
O
S
O
S S
OO
OOH
+
6 equiv MgBr2
.OEt2
16 (1 equiv)15 17  
Entry Conc  
CH2Cl2 (M) 
Yield  
(%) b 
Temp Diastereoselectivity c 
17-AA : 17-SA : 17-AS  : 
17-SS 
Non-Felkin/ 
Felkin ratio c 
17-SA :  
17-AA c 
1 0.9 28 rt 48 : 47 : 3 : 2 19/1 0.97 : 1.0 
2 0.3 19 rt 45 : 50 : 3 : 2 19/1 1.1 : 1.0 
3 0.1 26 rt 37 : 61 : 2 : 1 33/1 1.6 : 1.0 
4 0.03 23 rt 42 : 56 : 2 : 0 49/1 1.3 : 1.0 
5 0.01 23 rt 31 : 66 : 2 : 0 49/1 2.1 : 1.0 
6 0.3 27 0oC 38 : 54 : 2 : 6 12/1 1.4 : 1.0 
7 0.3 24 -20oC 29 : 65 : 1 : 4 18/1 2.2 : 1.0 
a Reactions conducted on 0.10-mmol scale following the General Procedure for aldol reactions 
of 16 with 15 via Soft Enolization except where noted.  b Determined via internal standard (1,4-
dicyanobenzene) by 1H NMR of the crude reaction mixture. c Determined by 1H NMR of the 
crude reaction mixture. 
The order of addition was again examined.  It was found that the order of addition had a 
large impact on the ratio of 17-SA and 17-AA formed in the reaction.  Adding the aldehyde 15 
to a solution of i-Pr2NEt, thiopyranone 16 and MgBr2·OEt2 resulted in a more favourable 17-
SA:17-AA ratio (0.9:1, Table 23, entry 2), allowing more direct access to the thermodynamically 
less stable 17-AA diastereomer.  Alternatively, adding aldehyde 15 pre-complexed with 
MgBr2·OEt2 resulted in the formation of numerous side products (Table 23, entry 3). 
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Table 23.  Effect of order of addition on the diastereoselectivity of MgBr2·OEt2 promoted aldol 
reaction between 15 and 16. 
S
0.03 M CH2Cl2, 
10 mins, rt
0.5 equiv i-Pr2NEtOO
H
O
S
O
S S
OO
OOH
+
6 equiv MgBr2
.OEt2
16 (1 equiv)15 17  
Entry Order of 
addition 
Yield (%) b Diastereoselectivity c 
17-AA : 17-SA : 17-AS : 
17-SS 
Non-Felkin/ 
Felkin c 
17-SA : 17-
AA c 
1 i-Pr2NEt last 36 34 : 64 : 2 : 1 35/1 1.9 : 1.0 
2 Aldehyde 15 last 33 51 : 45 : 3 : 1 23/1 0.9 : 1.0 
3 Aldehyde 15 last 
with 3 equiv’s 
MgBr2·OEt2 
34 d 50 : 47 : 3 : 0 28/1 0.93 : 1.0 
a Reactions conducted on 0.10-mmol scale following the General Procedure for aldol reactions 
of 16 with 15 via Soft Enolization except where noted. b Determined via internal standard (1,4-
dicyanobenzene) by 1H NMR of the crude reaction mixture. c Determined by 1H NMR of the 
crude reaction mixture. d Several side reactions occurring. 
The effect of the amount of i-Pr2NEt added was studied (Table 24).  By increasing the 
number of equivalents of i-Pr2NEt from 0.5 to 4.5 equivalents, the yield of all aldol adducts did 
not rise past the ca. 60% obtained with 1.5 equivalents of i-Pr2NEt.  When excess base is used, 
the amount of undesired side products increased.  Additionally, regardless of the amount of 
base employed, 6 equivalents of MgBr2·OEt2 were sufficient to keep a high non-Felkin/Felkin 
ratio.  
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Table 24.  Effect of the amount of i-Pr2NEt on the yield and diastereoselectivity of the 
MgBr2·OEt2 promoted aldol reaction between 15 and 16. 
a 
S
0.03 M CH2Cl2 
10 mins, rt
OO
H
O
S
O
S S
OO
OOH
+
6 equiv MgBr2
.OEt2
15 16 (1 equiv) 17
i-Pr2NEt
S S
OO
OOH
18
+
S
HO
OO
 
Entry Equiv i-Pr2NEt Yield (%) 
b, d Diastereoselectivity c, d 
17-AA : 17-SA : 17-AS : 
17-SS 
Non-
Felkin/Felkin 
ratio c 
17-SA : 17-
AA c 
1 0.5 26 39 : 59 : 2 : 0.5 39/1.0 1.5 : 1.0 
2 1.5 59 57 : 41: 2 : 0 49/1.0 0.73 : 1.0 
3 3 50 50 : 50 : 0 : 0 ND  d  1.0 : 1.0 
4 4.5 57 59 : 41 : ND : 0 e ND d 0.69 : 1.0 
5 1.5 f 82 57: 42 : 0 : 0 ND d 1.0 : 1.4 
6 1.5 g 63 58 : 43 : 0 : 0 ND d 1.0 : 1.3 
a Reactions conducted on 0.10-mmol scale following the General Procedure for aldol reactions 
of 16 with 15 via Soft Enolization except where noted. b Determined via internal standard (1,4-
dicyanobenzene) by 1H NMR of the crude reaction mixture. c Determined by 1H NMR of the 
crude reaction mixture. d Significant overlap of mono-aldol and bis-aldol diastereomers. e 
Overlap of side products with 17-SS and 17-AS. f i-Pr2NEt added fast.  
g i-Pr2NEt added over 3 
minutes. 
The six reaction mixtures described in Table 24 were combined and the products were 
isolated.  In addition to isolating 32% yield of 17 (as a 57:39:3:1 mixture of 17-AA, 17-SA, 17-AS 
and 17-SS, respectively), a mixture of bis-aldol adducts 18 (6% based on aldehyde) were also 
isolated.  The latter was tentatively identified as a 1:1:2 mixture of three previously unknown 
bis-aldol 18-SA-trans-SA, 18-AA-trans-AA, 18-SA-trans-AA, respectively.  Isolating bis-aldols 
was disappointing as it revealed that signals for the bis-aldols overlap with the signals from the 
non-Felkin mono-aldol adducts in the 1H NMR, complicating any efforts at further optimization.  
However, the formation of bis-aldols 18 was also promising because it was the first 
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demonstration that non-Felkin diastereoselectivity could be achieved in the aldol reaction of 17 
with 15. 
Taken together, the above results suggest that the reaction at 0.03 M in aldehyde, with 
2 equivalents of thiopyranone 16 and a 2:1 ratio of ketone 16 to i-Pr2NEt was optimal.  Under 
these conditions, the reaction resulted in good yield of aldol adducts (64% via internal 
standard) with a high non-Felkin/Felkin ratio (75/1) (Table 25, entry 1).  Using the same 
conditions except adding the aldehyde to a solution of the other reactants resulted in a relative 
increase in the amount of the least thermodynamically stable 17-AA diastereomer, although in 
low yield (Table 25, entry 2).  When 0.2 equivalents of i-Pr2NEt was used the conversion was 
lower than when one equivalent was used but a similar product ratio was obtained (entry 3, 
Table 25). 
Table 25.  Effect of order of addition on the diastereoselectivity and yield of the MgBr2·OEt2 
promoted aldol reaction between 15 and 16. 
S
0.03 M CH2Cl2, 
10 mins, OoC
1 equiv i-Pr2NEtOO
H
O
S
O
S S
OO
OOH
+
6 equiv MgBr2
.OEt2
16 (2 equiv)15 17  
Entry Order of Addition Yield 
17  
(%) a 
Diastereoselectivity b 
17-AA : 17-SA : 17-AS : 
17-SS 
Non-Felkin/ 
Felkin b 
17-SA : 17-
AA b 
1 i-Pr2NEt last 64 38 : 61 : 1 : 0 75/1 1.6 : 1.0 
2 15 last 18 67 : 33 : 0 : 0 c 1/0 0.5 : 1.0 c 
3 i-Pr2NEt last 
d 32 33 : 67 : 0 : 0 1/0 2.1 : 1.0 
a Reactions conducted on 0.10-mmol scale following the General Procedure for aldol reactions 
of 16 with 15 via Soft Enolization except where noted. a Determined via internal standard (1,4-
dicyanobenzene) by 1H NMR of the crude reaction mixture. b Determined by 1H NMR of the 
crude reaction mixture. c Overlap of bis-aldol diastereomers 18.  d 0.2 equivalents of i-Pr2NEt.  
Larger scale reactions (0.5 mmol of 15) were conducted under these conditions to 
obtain a 71% yield of 17-SA and 17-AA (Table 26, entry 1).  Increasing the amount of the ketone 
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16/i-Pr2NEt to 2.50/1.25 did not affect the yield of 17 or 18 but gave 17 with reduced 
stereoselectivity (Table 26, entry 2).  
Table 26.  Diastereoselectivity of MgBr2·OEt2 promoted aldol reactions of 15 and 16 
S
0.03 M CH2Cl2
10 mins, 0oC
OO
H
O
S
O
S S
OO
OOH
+
6 equiv MgBr2
.OEt2
15 (1 equiv) 16 17
i-Pr2NEt
S S
OO
OOH
18
+
S
OH
OO
 
Entry Equiv 16/ 
i-Pr2NEt 
Yield 17 
(%) b 
Diastereoselectivity b 
17-AA : 17-SA : 17-AS : 
17-SS 
Yield 
18 (%) 
b ,c 
Non-Felkin/ 
Felkin ratio b 
17-SA : 17-
AA b 
1 2.0/1.0 71 31 : 68 : 0.6 : 0 10 160/1.0 2.2 : 1.0 
2 2.50/1.25 70 44 : 53 : 2 : 0 12 44/1.0 1.2 : 1.0 
a Reactions conducted on 0.52-mmol scale following the Procedure for Aldol Reactions of 16 
with 15 via Soft Enolization except where noted. b Determined via isolation. c Based on 15. 
The protocol involving adding the aldehyde to a solution of the other reactants was also 
scaled-up.  On scale, this reaction resulted in 40% yield and poor non-Felkin/Felkin 
diastereoselectivity, with significant bis-aldol formation (Scheme 26). 
16 (2 equiv)
15
17, ca. 40% yield
17-AA (30) : 17-SA (45) : 17-AS (15) : 17-SS (9)
Non-Felkin/Felkin = 3/1
6 equiv MgBr2OEt2
S
0.03 M DCM wrt 15
1 equiv i-Pr2NEt
OO
H
O
S
O
S S
OO
OOH
+ +
O oC, 1.5 h
over 1.5 mins
18, ca. 40% yield
based on 15
S S
OO
OOH
+
S
OH
OO
 
Scheme 26.  Addition of 15 to a solution of the other reactants during the MgBr2·OEt2 
promoted aldol addition of 15 and 16 on 0.5-mmol scale. 
The above results show that the soft enolization methodology can be applied to the 
aldol reaction of aldehyde 15 and ketone 16 to produce the non-Felkin adducts 17-SA and 17-
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AA in 70% yield.  A drawback to this method is the competitive formation of bis-aldol adducts.  
As reported previously, the MgBr2·OEt2-mediated aldol reaction of 25 with 15 results in 61% of 
17-SA after one crystallization and a 4:1 mixture of 17-AA:17-SA that can be fractionated to 
give 6% 17-SA and 22% 17-AA (89% isolated yield of aldol adducts).7  Isomerization of the 17-SA 
in 1 M imidazole in CH2Cl2 after one day yields a 2:1 mixture of 17-SA:17-AA in 98% yield.
8  
After 2 cycles of isomerization, 59% of 17-AA can be obtained (Scheme 27).  Comparing this to 
the soft enolization methodology developed here, after one reaction and 2 isomerization 
cycles, 53% 17-AA can be obtained (Scheme 28).  Thus, the two methods are comparable for 
access to the 17-AA diastereomer however the Mukaiyama style aldol reaction has been 
performed on larger scale (5.74 mmol reported) and is superior for access to the 17-SA 
diastereomer. 
S
OH
S
MgBr2
.Et2O
imidazole
2:1 of 17-SA:17-AA
15 25
Mukaiyama-style aldol reaction
S
OO
H
O
S
OTMS
+
OO
O
67% of 17-SA
S
OH
S
OO
O
22% of 17-AA
+
1 isomerization
imidazole
2:1 of 17-SA:17-AA
45% of 17-SA 22% of 17-AA
2 isomerizations
30% of 17-SA 15% of 17-AA
30% of 17-SA 59% of 17-AA
 
Scheme 27.  Yield of 17-SA and 17-AA after the Mukaiyama style aldol reaction of 15 and 25 
followed by 2 isomerization reactions. 
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S
OH
S
imidazole
2:1 of 17-SA:17-AA
15 16
Soft enolization aldol reaction
i-Pr2NEt, 
MgBr2
.OEt2
S
OO
H
O
S
O
+
OO
O
38% of 17-SA
S
OH
S
OO
O
32% of 17-AA
+
1 isomerization
imidazole
2:1 of 17-SA:17-AA
25% of 17-SA 13% of 17-AA
2 isomerizations
17% of 17-SA 8% of 17-AA
17% of 17-SA 53% of 17-AA  
Scheme 28.  Yield of 17-SA and 17-AA after the soft enolization aldol reaction of 15 and 16 
followed by 2 (hypothetical) isomerization reactions. 
 
2.5. Aldol Reactions using Soft Enolization – Bis-aldol 
formation 
 
After exploration of the MgBr2·OEt2 promoted aldol reaction of 15 with 16, the soft 
enolization methodology was applied to the aldol reaction of 15 with 17.   An aldol reaction of 
15 with 17 can produce twenty unique bis-aldol diastereomers 18, six of which had not been 
previously synthesized.  These six unknown diastereomers all share the common feature of 1’,6’ 
anti and 1’’, 6’’ anti relative configurations (Scheme 18); they can arise from non-Felkin 
additions to 17-SA and 17-AA.  The 1’,6’ anti configuration is strongly favoured under the soft 
enolization conditions in the aldol addition of 15 and 16 producing selectively 17-SA and 17-AA. 
It was hypothesized that applying the same methodology to the reactions of 15 with 17-SA and 
17-AA would have the potential to generate any of the remaining unknown bis-aldol 18 
diastereomers. 
Aldol reactions of chiral reactants such as 17 and 15 exhibit three stereocontrol 
elements: aldol relative topicity, enolate face selectivity and aldehyde face selectivity (Figure 
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12).  With respect to the TR2P, the relative topicity (5,1’’-syn or 5,1’’-anti) of the aldol coupling 
can be controlled by employing titanium or boron enolates of 17.  The diastereoface selectivity 
of the ketone enolate is governed by the nature of the protecting group on the C-1’ hydroxyl 
group.  β-alkoxy ketones (Figure 12, R=MOM, Et3Si, or Ac) generally undergo aldol reactions to 
give 3,5-trans products while β-hydroxy ketones (Figure 12, R=H) under certain conditions 
undergo aldol reactions to give 3,5-cis products.  Aldehyde 15 strongly favours Felkin 
diastereoface selectivity (1’’,6’’-syn relative configuration).  In the reaction with 16, non-Felkin 
diastereoface selectivity can be achieved in the presence of MgBr2·OEt2.  However, prior to this 
work, all attempts to obtain non-Felkin diastereoface selectivity in the aldol reaction of 15 with 
17 had failed.   
S S
OO
OOR
S
HO
OO
aldehyde face selectivity
enolate face selectivity
relative aldol topicity
6'
1'
6''53
1''
18  
Figure 12.  Relationship between the relative configuration of bis-aldol adduct 18 and the 
underlying three stereocontrol elements. 
The soft enolization reaction chemistry was first explored with 17-SA.  No reaction 
occurred when the free alcohol was present (Figure 13).  Protecting the alcohol was necessary 
and the two protecting groups chosen for study were methoxymethyl (MOM) and triethylsilyl 
(TES) as these derivatives were previously utilized successfully in the TR2P (Scheme 29).  
S
2 equiv i-Pr2NEt,
6 equiv MgBr2
.OEt2O O
H
O
S S
OO
OOH
+ 0.3 CH2Cl2, rt, 12 h
1517-SA (2 equiv)
NO REACTION
 
Figure 13.  Failed MgBr2·OEt2 promoted aldol reaction between 17-SA and 15. 
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S
OO
HO
S
O
S
OO
HO
S
O
17-AA
17-SA
Et3Si-OTf
2,6-dimethyl
pyridine, 95%
MOM-Cl,
i-Pr2NEt, Bu4NI
S
OO
HO
S
O
S
OO
HO
S
O
17-SS
17-AS
MOM-Cl,
i-Pr2NEt, Bu4NI
S
OO
O
S
O
S
OO
O
S
O
17-AA-MOM
17-SA-MOM
Et3Si-OTf
Et3Si-OTf,
Pyridine
Et3Si-OTf,
Pyridine
S
OO
O
S
O
S
OO
O
S
O
17-AA-TES
17-SA-TES
S
OO
O
S
O
S
OO
O
S
O
17-SS-TES
17-AS-TES
Et3Si H3COCH2
H3COCH2
Et3Si
Et3Si
Et3Si
2,6-dimethyl
pyridine, 97%
91%
96%
96%
95%
 
Scheme 29.  Protection of mono-aldol adducts 17 with MOM and TES protecting groups.8, 10 
The aldol addition of 15 and 17 was explored initially using the conditions optimized for 
the aldol reaction of 15 with 16.  The first substrate examined was 17-SA-TES.  Using one 
equivalent each of i-Pr2NEt, aldehyde 15 and ketone 17-SA-TES, 6 equivalents of MgBr2·OEt2, at 
0 oC in CH2Cl2 resulted in a highly diastereoselective aldol addition where only 2 of 8 possible 
diastereomers were detected in moderate yield (Entry 1, Table 27).  Both of the products had 
trans relationship across the middle ring (3,5-trans) and arose from non-Felkin addition to 
aldehyde 15 (1’’, 6’’-anti), however they differed in their relative aldol topicity (5,1’’-syn versus 
5-1’’-anti).  The syn aldol 18-SA-TES-trans-SA was favoured over the anti aldol 18-SA-TES-trans-
AA by 2.5:1.  As was the case with the MgBr2·OEt2 promoted aldol addition of 15 and 16, 
doubling the amount of i-Pr2NEt did not improve the yield and the diastereoselectivity 
remained the same (Entry 2, Table 27).   
Concentration effects were explored for the 17-SA-TES substrate (Table 27, Entry 1, 3, 
4).  Higher concentration disfavoured formation of the product.  Moreover, a marked difference 
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in the diastereoselectivity was observed at higher concentration, nearly 6:1 ratio in favour of 
the syn aldol product 18-SA-TES-trans-SA, however the yield was dramatically reduced (Table 
27, Entry 4).  The highest yield was obtained with a 0.03 M solution, therefore this 
concentration was employed for all other experiments (Table 27, Entry 1).  Changing the order 
of addition by adding the ketone 17-SA-TES last resulted in a similar yield as adding the base 
last (Table 27, entry 5). 
The yield of the aldol addition of 15 with 17-SA-TES was moderate, therefore two other 
bases were tried.  No reaction occurred using pyridine as the base.  The use of 2,6-lutidine 
could promote an aldol addition under these conditions, albeit in much lower yield than i-
Pr2NEt (Table 27, entry 6, 7).  
On scaling up, the aldol addition of 15 with 17-SA-TES gave a combined 68% yield of the 
two bis-aldols diastereomers 18-SA-TES-trans-SA and 18-SA-TES-trans-AA.  This yield was 
higher than expected judging from the experiments performed on smaller scale (Table 27, Entry 
1 vs Entry 8). 
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 Table 27.  Diastereoselectivity of MgBr2·OEt2 promoted aldol reaction between 15 and 17-SA-
TES 
S
1 equiv i-Pr2NEt,
6 equiv MgBr2
.OEt2O O
H
O
S S
OO
OO
+ 0 oC, 60 mins
TES
S S
OO
OO
TES
S
OO
HO
15 (1 equiv)17-SA-TES (1 equiv) 18-SA-TES-trans-SA
S S
OO
OO
TES
S
OO
HO
18-SA-TES-trans-AA  
Entry Conc CH2Cl2 (M) Yield (%) 
a, b Diastereoselectivity a 
18-SA-TES-trans-SA : 18-SA-TES-trans-AA 
1 0.03 49 2.5 : 1.0 
2 c 0.03 31 2.5 : 1.0 
3 0.01 41 2.4 : 1.0 
4 0.09 12 5.9 : 1.0 
5 d 0.03 54 3.0 : 1.0 
6 e 0.03 0 - 
7 f 0.03 22 4.8 : 1.0 
8 g 0.03 68 h 3.5 :1.0 
a Determined via internal standard (1,4-dicyanobenzene) by 1H NMR of the crude reaction 
mixture. b Combined yields via internal standard of both diasteromers of 18.  c 2 equivalents of 
i-Pr2NEt. 
d Addition of ketone last. e Pyridine used as the base. f 2,6-Lutidine as the base. g 100 
mg of 17-AS-TES. h Combined isolated yield of both diastereomers of 18. 
Reaction of 15 with 17-SA-MOM gave similar results to those obtained with 17-SA-TES.  
Using one equivalent each of i-Pr2NEt, aldehyde 15 and ketone 17-SA-MOM, 6 equivalents of 
MgBr2·OEt2, at 0 
oC in CH2Cl2 resulted in a highly diastereoselective aldol addition where only 2 
of 8 possible diastereomers were detected in low yield (entry 1, Table 28).  As with the 17-SA-
TES substrate, both products had a trans relationship across the middle ring (3,5-trans) and 
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arose from non-Felkin addition to 15 (1’’, 6’’-anti), however they differed in their relative 
configuration (5,1’’-syn versus 5,1’’-anti). 
Examinations of the stoichiometry and reaction time were conducted for the reaction of 
15 with 17-SA-MOM.  Changing the excess reactant from aldehyde 15 to ketone 17-SA-MOM or 
i-Pr2NEt only resulted in minor changes in the yield and diastereoselectivity.  In all cases, the 
yields were less than 40% with close to 1:1 diastereoselectivity (Table 28). 
Table 28.  Diastereoselectivity of MgBr2·OEt2 promoted aldol reaction between 15 and 17-SA-
MOM at various stoichiometries 
S
i-Pr2NEt, 
6 equiv MgBr2
.OEt2O O
H
O
S S
OO
OO
+
MOM
S S
OO
OO
MOM
S
OO
HO
15 18-SA-MOM-trans-SA
S S
OO
OO
MOM
S
OO
HO
18-SA-MOM-trans-AA
0.03 M CH2Cl2 wrt ald
0 oC, 60 mins
17-SA-MOM  
Entry Ald 15 (equiv) 17-SA-
MOM 
(equiv) 
Equiv 
i-Pr2NEt 
Yield 
(%) a, b 
Diastereoselectivity a 
18-SA-trans-SA : 18-SA-trans-
AA 
1 1 1 1 38 1.0 : 1.2 
2 2 1 1 25 1.3 : 1.0 
3 1 2 1 30 1.0 : 1.3 
4 1 1 2 37 1.1 : 1.0 
a Determined via internal standard (1,4-dicyanobenzene) by 1H NMR of the crude reaction 
mixture. b Combined yield via internal standard of both diastereomers of 18. 
A time course study was performed on the reaction of 15 with 17-SA-MOM to 
determine the optimal reaction time (Table 29).  The reaction reached a maximum completion 
within ten (35% yield) and the yield slowly decreased with increasing reaction time, suggesting 
that the bis-aldol products 18-SA-MOM-trans-SA and 18-SA-MOM-trans-AA are not indefinitely 
stable to the reaction conditions. 
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Table 29.  Diastereoselectivity of MgBr2·OEt2-promoted aldol reaction between 15 and 17-SA-
MOM at various reaction times 
S
i-Pr2NEt,
6 equiv MgBr2
.OEt2O O
H
O
S S
OO
OO
+
MOM
S S
OO
OO
MOM
S
OO
HO
15 (1 equiv) 18-SA-MOM-trans-SA
S S
OO
OO
MOM
S
OO
HO
18-SA-MOM-trans-AA
0.03 M CH2Cl2 wrt ald
17-SA-MOM (1 equiv)
0 oC
 
Entry Time (min) Yield (%) a, b Diastereoselectivity a 
18-SA-trans-SA : 18-SA-trans-AA 
1 10 35 1.0 : 1.6 
2 60 27 1.0 : 2.0 
3 120 25 1.0 : 2.0 
a Determined via internal standard (1,4-dicyanobenzene) by 1H NMR of the crude reaction 
mixture. b Combined yield via internal standard of both diastereomers of 18. 
Taken together, the above results from the reactions of 15 with 17-SA-TES and 17-SA-
MOM suggest that a short reaction time is important, with an initial aldehyde concentration of 
0.03 M and with equimolar amounts of aldehyde, ketone and base.  MgBr2·OEt2 promoted aldol 
reactions of 15 with 17-AA-TES, 17-AA-MOM, 17-AS-TES and 17-SS-TES were also examined 
and the results are collected in Table 30. 
Table 30.  Results of the MgBr2·OEt2-promoted aldol reaction between 15 and 17-AA-TES, 17-
AA-MOM, 17-AS-TES, or 17-SS-TES 
S
1 equiv i-Pr2NEt,
6 equiv MgBr2
.OEt2
O O
H
O
S S
OO
OO
+
0.03 M CH2Cl2
0 oC, 60 mins
PG
S S
OO
OO
PG
S
OO
HO
15 (1 equiv)17-XX-PG (1 equiv) 18-XX-PG-trans-SA
S S
OO
OO
PG
S
OO
HO
18-XX-PG-trans-AA  
Entry Ketone 
diastereomer 
PG Yield (%) a, b Diastereoselectivity a 
18-XX-PG-trans-AA : 18-XX-PG-trans-SA 
1 AA TES 31 1.8 : 1.0 
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2 c AA TES 45 f 1.8 : 1.0 
3 AA MOM n.d. n.d. 
4 d AS TES 66 f 1.5 : 1.0 
5 e SS TES 27 f 1.0 : 1.0 
a Determined via internal standard (1,4-dicyanobenzene) by 1H NMR of the crude reaction 
mixture. b Combined yield via internal standard of both diastereomers of 18.  c 200 mg scale. d 
Reaction time 15 minutes. e Reaction time 30 minutes.  f Combined isolated yield of both 
diastereomers of 18. 
As was observed for the reaction with 17-SA-TES, scaling up the reaction of 15 with 17-
AA-TES resulted in a slightly higher yield than what was expected from the reactions performed 
on small scale (Table 30, Entries 1 and 2).  Again, only 2 of 8 possible diastereomers were 
detected; both resulted from trans addition to the enolate and non-Felkin addition to the 
aldehyde but they differed in relative aldol topicity (5,1’’-syn versus 5,1’’-anti).  Unlike the 17-
SA-TES substrate, eliminated products as well as other side products were detected.  
Interestingly, the reaction of 15 with 17-AA-MOM yielded dramatically different results than all 
the other substrates explored (Table 30, entry 3).  Instead of producing two diastereomers as in 
the other substrates investigated, multiple inseparable products were generated.  Further 
reactions of this substrate were not explored.  Aldol reactions of aldehyde 15 with 17-SS-TES 
and 17-AS-TES were also conducted (Table 30, entry 4 and 5).  In each case, only 2 of 8 possible 
diastereomers were formed.  Both resulted from trans addition to the enolate and non-Felkin 
addition to the aldehyde but differ in 5,1’’-syn versus 5,1’’-anti relative aldol topicity. 
Substrates examined for the second aldol reaction were: 17-SA-TES, 17-SA-MOM, 17-
AA-TES, 17-AA-MOM, 17-AS-TES and 17-SS-TES.  Reactions employing the soft enolization 
conditions on the second aldol reaction of the TR2P resulted in high diastereoselectivity (only 2 
of 8 possible diastereomers detected) in moderate to low yields except for the 17-AA-MOM 
substrate.  Conditions explored to increase the yields of the bis-aldol adducts included varying 
1) the relative amounts of base, starting ketone 17, and aldehyde 15, 2) the nature of the amine 
base, 3) the concentration, and 4) the reaction time.  None of these parameters increased the 
yields of the bis-aldol adducts to any significant extent.  In addition to the moderate to low 
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yields, there was low recovery of the starting materials (ketone 17 and aldehyde 15).  When the 
protected ketones were subjected to the reaction conditions in the absence of aldehyde, only 
64% of the ketone was recovered after work-up and the fate of the consumed starting material 
could not be determined.  Thus, optimization efforts were discontinued because the reaction 
performed in this way allows too many uncontrollable side reactions that compete with 
product yield and starting material recovery.  Nevertheless, the soft enolization methodology 
gave access to 3 previously unknown bis-aldol diastereomers (after deprotection: 17-AA-TES-
trans-AA, 17-SA-TES-trans-SA [17-SA-MOM-trans-SA], and 17-AA-TES-trans-SA = 17-SA-TES-
trans-AA [17-SA-MOM-trans-AA]).  However, an improved method will be required to access 
synthetically useful amounts of these materials. 
2.6. Determination of configuration of aldol diastereomers of 
18 
 
To confirm the relative configurations of the bis-aldol diastereomers of 18 produced in 
the above reaction, the protecting groups of the aldol adducts were removed.  The number of 
resonances in the 13C NMR gives key pieces of information regarding the symmetry of the bis-
aldols.  Of the twenty diastereomers of 18, there are 4 Cs, 4 C2 and 12 C1 symmetric bis-aldols; 
by determining the symmetry, the number of candidate diastereomers for a given isomer is 
reduced.  Unsymmetrical bis-aldol adducts (C1) have 21 resonances in the 
13C NMR while 
symmetric adducts (C2, Cs) only have 11 resonances.  Symmetric bis-aldols can be either C2 or Cs 
symmetrical and they can be distinguished from each other by reduction to the corresponding 
triol.  Cs symmetric bis-aldols will give Cs symmetric triols while C2 symmetric bis-aldols will 
reduce to give unsymmetrical triols (Figure 14). 
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Figure 14.  Symmetry relationship between bis-aldol adduct and subsequent triol for structure 
determination. 
As shown in the introduction, β-hydroxy ketones (both from mono-aldol adducts 17 and 
bis-aldol adducts 18) from the TR2P isomerize in the presence of imidazole.  Isomerization of 
bis-aldols 18 also can be used to aid in structure determination.  Additionally, isomerization can 
also be used to generate the three remaining unknown bis-aldols (18-SA-cis-SA, 18-AA-cis-AA, 
18-SA-cis-AA) that could not be formed directly from the soft enolization methodology. 
2.6.1. Bis-aldol 18-SA-TES-trans-SA and 18-SA-MOM-trans-SA 
 The adduct 18-SA-TES-trans-SA was obtained as the major product both from the aldol 
reaction of 17-SA-TES with 15 and the adduct 18-SA-MOM-trans-SA from the aldol reaction of 
17-SA-MOM with 15 (Figure 15).  The vicinal coupling constants between H2C-2 and HC-3 (7 and 
10 Hz) and between HC-5 and H2C-6 (5 and 12 Hz) in the 
1H NMR spectrum of 18-SA-TES-trans-
SA suggests a trans 3,5-disubstituted thiopyranone ring in a twist-boat conformation.  This 
compound also exhibits unique properties in the 13C NMR; carbons C-2 and C-6 have chemical 
shifts of 23.8 and 22.1 ppm respectively, which are around 4 ppm upfield from “normal” and 
again consistent with an unusual conformation.  Analysis of the vicinal coupling constants 
between H2C-2 and HC-3 (7 and 9.5 Hz) and between HC-5 and H2C-6 (5.5 and 11.5 Hz) in the 
1H 
NMR spectrum of 18-SA-MOM-trans-SA indicate that the substituents at positions C-3 and C-5 
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of the thiopyranone ring were trans and that the conformation was unusual.  Additionally, the 
X-ray crystal structure of 18-SA-MOM-trans-SA confirmed the twist-boat conformation 
observed in the 1H NMR spectrum (Figure 16). 
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15 18-SA-TES-trans-SA R=TES
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17-SA-TES R=TES
17-SA-MOM R=MOM
S S
OO
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S
OO
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18-SA-trans-SA
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or
TiCl4/PhSH
(35%)
 
Figure 15.  Determination of the relative configuration of 18-SA-TES-trans-SA and 18-SA-MOM-
trans-SA. 
 
Figure 16.  X-ray crystal structure determination of relative configuration of 18-SA-MOM-trans-
SA. 
2.6.2. Bis-aldol 18-SA-trans-SA 
Removal of the silyl protecting group in 18-SA-TES-trans-SA by treatment with 
HF·pyridine/pyridine and of the MOM ether in 18-SA-MOM-trans-SA by treatment with 
TiCl4/PhSH gave the bis-aldol 18-SA-trans-SA in quantitative and 35% yields respectively (Figure 
15).  This adduct is symmetric as indicated by the presence of only 11 resonances in the 13C 
NMR spectrum.  Symmetric bis-aldol adducts can be Cs or C2 symmetric.  These possibilities can 
be distinguished by reduction to the triol as Cs symmetric bis-aldols will give symmetric triols (as 
indicated by 11 resonances in the 13C NMR spectrum) while C2 bis-aldols will produce non-
symmetric triols (as indicated by 21 resonances in the 13C NMR spectrum).  Reduction of 18-SA-
trans-SA with NaBH4 gave the unsymmetric triol 191 (40% isolated yield
3).  The triol was 
                                                          
3
 Low isolated yield due to incomplete removal of the salts formed during the reaction. 
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unsymmetric as indicated by the presence of 21 resonances in the 13C NMR spectrum; this 
result indicates that 18-SA-trans-SA was a C2 symmetric bis-aldol adduct.  Of the twenty 
possible bis-aldol diastereomers, there are 4 Cs, 4 C2 and 12 C1 symmetric bis-aldols.  The 
structure of 18-SA-trans-SA is established because of the four C2 symmetric bis-aldol adducts 
possible, only one can result from an aldol reaction of 17-SA-TES or 17-SA-MOM. 
S S
OO
OHOH
S
OO
HO
S S
OO
OOH
S
OO
HO NaBH4
40% yield
18-SA-trans-SA 191  
Figure 17.  Reduction of the symmetric diol 18-SA-trans-SA to an unsymmetric triols confirms 
the diol is C2 symmetric. 
The structure of 18-SA-trans-SA was further confirmed by imidazole catalyzed 
isomerization (Figure 18).  A solution of 18-SA-trans-SA in 0.3 M imidazole in CDCl3 was 
prepared and monitored by 1H NMR.   An equilibrium mixture of 18-SA-cis-AA (47%), 18-SA-
trans-SA (26%) and 18-AA-trans-AA (26%) was found after 11 days. 
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Figure 18.  Isomerization of 18-SA-trans-SA with 0.3 M imidazole in CDCl3. 
2.6.3. Bis-aldol 18-AA-TES-trans-AA 
 The adduct 18-AA-TES-trans-AA was obtained as the major product from the aldol 
reaction of 17-AA-TES with 15 (Figure 19).  The vicinal coupling constants between H2C-2 and 
HC-3 (5, 5.5 Hz) in the 1H NMR spectrum of 18-AA-TES-trans-AA indicated that the substituents 
at positions C-3 and C-5 of the thiopyranone ring were trans.  The structure of 18-AA-TES-trans-
AA was assigned based on its deprotection product 18-AA-trans-AA. 
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Figure 19.  Determination of the relative configuration of 18-AA-TES-trans-AA. 
2.6.4. Bis-aldol 18-AA-trans-AA 
Removal of the silyl protecting group in 18-AA-TES-trans-AA under HF·pyridine/pyridine 
conditions gave 18-AA-trans-AA in quantitative yield (Figure 19).  This adduct is symmetric as 
indicated by the presence of only 11 resonances in the 13C NMR spectrum.  Symmetric bis-aldol 
adducts can be Cs or C2 symmetric.  They can be distinguished from each other by reduction to 
the triol as Cs symmetric adducts will give symmetric triols (as indicated by 11 resonances in the 
13C NMR spectrum) while C2 adducts will reduce to non-symmetric triols (as indicated by 21 
resonances in the 13C NMR spectrum).  Reduction of 18-AA-trans-AA with NaBH4 gave the 
unsymmetric triol 191 (89% isolated yield).  The triol was unsymmetric as indicated by the 
presence of 21 resonances in the 13C NMR spcectrum; this result indicates that 18-AA-trans-AA 
was a C2 symmetric bis-aldol adduct.  Of the twenty bis-aldol diastereomers, there are 4 Cs, 4 C2 
and 12 C1 symmetric bis-aldols.  The structure of 18-AA-trans-AA is established because of the 
four C2 symmetric bis-aldol adducts possible, only one can result from an aldol reaction of 17-
AA-TES.  Additionally, with the obtention of 18-SA-trans-SA and 18-AA-trans-AA all 4 possible 
C2 symmetric bis-aldols 18 are known: one from each of the 4 possible diastereomers 17. 
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HO NaBH4
89% yield
18-AA-trans-AA 191  
Figure 20.  Reduction of the symmetric diol 18-AA-trans-AA to an unsymmetric triol confirms 
the diol is C2 symmetric. 
The structure of 18-AA-trans-AA was further confirmed by imidazole catalyzed 
isomerization.  In 0.3 M imidazole in CDCl3, an equilibrium mixture of 18-SA-cis-AA (46%), 18-
SA-trans-SA (29%) and 18-AA-trans-AA (25%) was obtained after 3 days (Figure 21). 
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Figure 21.  Isomerization of 18-AA-trans-AA with 0.3 M imidazole in CDCl3. 
2.6.5. Bis-aldol 18-SA-TES-trans-AA and 18-SA-MOM-trans-AA 
 The adduct 18-SA-TES-trans-AA was obtained as the minor product from the aldol 
reaction of 17-SA-TES with 15; the adduct 18-SA-MOM-trans-AA was obtained from the aldol 
reaction of 17-SA-MOM with 15 (Figure 22).  The vicinal coupling constants between H2C-2 and 
HC-3 (8 and 8 Hz, respectively) and between HC-5 and H2C-6 (4 and 8 Hz, respectively) in the 
1H 
NMR spectrum of 18-SA-TES-trans-AA indicate a trans 3,5-disubstituted thiopyranone ring.  An 
X-ray crystal structure of 18-SA-TES-trans-AA confirmed the stereochemical assignment (Figure 
23).  Analysis of the vicinal coupling constants between H2C-2 and HC-3 (6.5 and 10.5 Hz, 
respectively) and between HC-5 and H2C-6 (5 and 9 Hz, respectively) in the 
1H NMR spectrum of 
18-SA-MOM-trans-AA indicated that the substituents at positions C-3 and C-5 of the 
thiopyranone ring were trans.  The structure of 18-SA-MOM-trans-AA was assigned based on 
its deprotection product 18-SA-trans-AA. 
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Figure 22.  Determination of the relative configuration of 18-SA-TES-trans-AA and 18-SA-MOM-
trans-AA. 
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Figure 23.  X-ray crystal structure determination of relative configuration of 18-SA-TES-trans-
AA. 
2.6.6. Bis-aldol 18-SA-trans-AA (=18-AA-trans-SA) 
Removal of the silyl protecting group in 18-SA-TES-trans-AA by reaction with 
HF·pyridine/pyridine and the MOM ether in 18-SA-MOM-trans-AA by reaction with TiCl4/PhSH 
gave 18-SA-trans-AA (=18-AA-trans-SA) in 93% and 57% conversions (determined from the 1H 
NMR spectrum), respectively (Figure 22).  This adduct is unsymmetrical as indicated by the 
presence of 21 resonances in the 13C NMR spectrum.  The structure of 18-SA-trans-AA is 
inferred from that of the precursor 18-SA-TES-trans-AA (X-ray).  The structure of 18-SA-trans-
AA is further confirmed because the same adduct is obtained from deprotection of 18-AA-TES-
trans-SA and isomerization gives 2 Cs symmetric bis-aldols (vide infra). 
2.6.7. Bis-aldol 18-AA-TES-trans-SA 
 The adduct 18-AA-TES-trans-SA was obtained as the minor product from the aldol 
reaction of 17-AA-TES with 15 (Figure 24).  The coupling constants of HC-3 (ddd, 5, 5 and 5 Hz) 
in the 1H NMR of 18-AA-TES-trans-SA indicates that the substituents at positions C-3 and C-5 of 
the thiopyranone ring were trans; the HC-5 peak was buried and the HC-6 was strongly coupled.  
The structure of 18-AA-TES-trans-SA is assigned based on its deprotection product 18-AA-
trans-SA (vide infra, section 2.6.8).   
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Figure 24.  Determination of the relative configuration of 18-AA-TES-trans-SA. 
2.6.8. Bis-aldol 18-AA-trans-SA (=18-SA-trans-AA) 
Removal of the triethylsilyl protecting group in 18-AA-TES-trans-SA by treatment with 
HF·pyridine/pyridine conditions gave 18-AA-trans-SA (=18-SA-trans-AA) in 70% yield (Figure 
24).  This adduct is unsymmetrical as indicated by the presence of 21 resonances in the 13C 
NMR spectrum and is identical to the product 18-SA-trans-AA described previously.  The 
structure of 18-AA-trans-SA (=18-SA-trans-AA) is established because of the twelve C1 
symmetric bis-aldol adducts possible, only one can be trans across the ring and result from 
deprotection of aldol adducts from reaction of 15 with 17-AA-TES and 17-SA-TES and 17-SA-
MOM. 
The imidazole-catalyzed isomerization of bis-aldol 18-SA-trans-AA was examined.  The 
isomerization of 18-SA-trans-AA in 0.3 M imidazole in CDCl3 gave an equilibrium mixture in 2-3 
days with the 18-SA-trans-AA diastereomer predominating (46%), and two previously unknown 
Cs compounds 18-SA-cis-SA (43%) and 18-AA-cis-AA (11%) (Figure 25).  Only 18-SA-trans-AA 
could isomerize via enolization to produce 18-SA-cis-SA and 18-AA-cis-AA, firmly establishing 
the relative configuration of this adduct. 
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Figure 25.  Isomerization of 18-SA-trans-AA with 0.3 M imidazole in CDCl3. 
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2.6.9. Bis-aldol 18-AS-TES-trans-SA 
 The adduct 18-AS-TES-trans-SA was obtained as the minor product from the aldol 
reaction of 17-AS-TES with 15 (Figure 26).  Removal of the triethylsilyl protecting group under 
HF·pyridine/pyridine conditions gave 18-AS-trans-SA (=18-SA-trans-AS) (quantitative yield) 
whose structure determination has been previously described.11 
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Figure 26.  Determination of the relative configuration of 18-AS-TES-trans-SA. 
2.6.10. Bis-aldol 18-AS-TES-trans-AA 
 The adduct 18-AS-TES-trans-AA was obtained as the major product from the aldol 
reaction of 17-AS-TES with 15 (Figure 27).  Removal of the triethylsilyl protecting group under 
HF·pyridine/pyridine conditions gave 18-AS-trans-AA (=18-AA-trans-AS) (quantitative yield) 
whose structure determination has been previously described.11 
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Figure 27.  Determination of the relative configuration of 18-AS-TES-trans-AA. 
2.6.11. Bis-aldol 18-SS-TES-trans-SA 
 The adduct 18-SS-TES-trans-SA was obtained from the aldol reaction of 17-SS-TES with 
15 (Figure 28).  Removal of the triethylsilyl protecting group under HF·pyridine/pyridine 
conditions gave 18-SS-trans-SA (=18-SA-trans-SS) (quantitative yield) whose structure 
determination has been previously described.11 
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Figure 28.  Determination of the relative configuration of 18-SS-TES-trans-SA. 
2.6.12. Bis-aldol 18-SS-TES-trans-AA 
 The adduct 18-SS-TES-trans-AA was obtained from the aldol reaction of 17-SS-TES with 
15 (Figure 29).  Removal of the triethylsilyl protecting group under HF·pyridine/pyridine 
conditions gave 18-SS-trans-AA (=18-AA-trans-SS) (quantitative yield) whose structure 
determination has been previously described.11 
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Figure 29.  Determination of the relative configuration of 18-SS-TES-trans-AA. 
2.6.13. Bis-aldol 18-SA-cis-SA 
The isomerization of 18-SA-trans-AA (=18-AA-trans-SA) in 0.3 M imidazole in CDCl3 gave 
an equilibrium mixture in 2-3 days with the 18-SA-trans-AA diastereomer predominating (46%), 
and two Cs compounds: 18-SA-cis-SA (43%) and 18-AA-cis-AA (11%) (Figure 25).  At present, 
this is the only route to these adducts.  18-SA-cis-SA is symmetrical as indicated by the 
presence of only 11 resonances in the 13C NMR spectrum.  The structure of 18-SA-cis-SA is 
assigned based on the chemical shift of 70.8 ppm for C-1’/1’’ in the 13C NMR spectrum; this 
result is consistent with the syn-anti relative configuration (7 examples). 
2.6.14. Bis-aldol 18-AA-cis-AA 
The isomerization of 18-SA-trans-AA (=18-AA-trans-SA) in 0.3 M imidazole in CDCl3 gave 
an equilibrium mixture in 2-3 days with the 18-SA-trans-AA diastereomer predominating (46%), 
and two Cs compounds: 18-SA-cis-SA (43%) and 18-AA-cis-AA (11%) (Figure 25).  18-AA-cis-AA 
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is symmetrical as indicated by the presence of only 11 resonances in the 13C NMR spectrum.  
The structure of 18-AA-cis-AA is assigned based on the chemical shift of 72.4 ppm for C-1’/1’’ in 
the 13C NMR spectrum; this result is consistent with the anti-anti relative configuration (7 
examples). 
2.6.15. Bis-aldol 18-SA-cis-AA (=18-AA-cis-SA) 
The isomerization of 18-AA-trans-AA in CH2Cl2 with imidazole for 3 days at room 
temperature gave a mixture of 18-SA-cis-AA (46%), 18-SA-trans-SA (29%) and 18-AA-trans-AA 
(25%) (Figure 21).  The equilibrium ratio was confirmed by isomerising 18-SA-trans-SA in 0.3 M 
imidazole in CDCl3 was prepared and monitoring by 
1H NMR.   A comparable equilibrium 
mixture of 18-SA-cis-AA (47%), 18-SA-trans-SA (26%) and 18-AA-trans-AA (26%) was obtained 
after 11 days (Figure 18).  18-SA-cis-AA (=18-AA-cis-SA) is unsymmetrical as indicated by the 
presence of 21 resonances in the 13C NMR spectrum.  The structure of 18-SA-cis-AA (=18-AA-
cis-SA) is established because it is the only possible bis-aldol adduct that can be obtained from 
the imidazole-catalyzed isomerizations of 18-AA-trans-AA and 18-SA-trans-SA. 
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3. CONCLUSION 
The initial goal of this project was to access the enantioenriched non-Felkin (C1’-C6’’ 
anti) diastereomers of the first aldol reaction.  This would necessitate controlling both the 
diastereo- and enantioselectivity during the reaction of 15 with 16 and it must be achieved in 
good yield.  The challenge is to overcome the inherent preference for Felkin addition to 
aldehyde 15.  Conditions for the first aldol reaction have been explored using chiral transition 
metal-based Lewis acids and organocatalysts with chelating Lewis acid additives to access non-
racemic non-Felkin first aldol adducts.  Despite extensive experimentation, the direct synthesis 
of non-racemic 17-AA and 17-SA remains elusive at this time. 
The soft enolization methodology was applied to the first and second aldol reactions of 
the TR2P.  The method developed for the synthesis of 17-AA was shown to be comparable in 
yield to the previously reported Mukaiyama-type aldol reaction; the Mukaiyama aldol reaction 
is superior for access to the 17-SA diastereomer.  The soft enolization methodology was 
successfully applied to the formation of the non-Felkin bis-aldol diastereomers 18.  Three of the 
previously six unknown diastereomers are available selectively via this new route.  Although the 
yields were moderate, the reaction was highly stereoselective, cleanly producing only two of 
eight possible diastereomers for reactions with 17-SA-TES, 17-AA-TES, 17-SA-MOM, 17-AS-TES 
and 17-SS-TES.  The yields will need to be improved for future synthetic applications of these 
adducts; however, single adducts might be available by using enantiopure reactants.  Although 
the cis-substituted bis-aldol adducts (18-SA-cis-SA, 18-SA-cis-AA, and 18-AA-cis-AA) are not 
available directly, they can be obtained through isomerization.  Thus, all of the 20 bis-aldol 
diastereomers of the TR2P are now known and can be obtained via sequential aldol reactions of 
15 with 16 in 2-5 steps. 
3.1. Future Directions 
The soft enolization methodology gave access to non-Felkin first-aldol diastereomers 
and 3 previously unknown bis-aldol diastereomers; however, an improved method will be 
required to access synthetically useful amounts of these materials.  Pre-forming the magnesium 
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(II) enolate (e.g., prepared from X-Mg-NR base) and reacting with aldehyde 15 pre-complexed 
with MgBr2·OEt2 could potentially maintain the non-Felkin diastereoselectivity while improving 
the yield of the first and second aldol reactions.27 
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Figure 30.  Pre-forming the magnesium (II) enolate. 
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4. EXPERIMENTAL 
4.1. GENERAL METHODS 
Anhydrous solvents were distilled under an argon atmosphere as follows:  
tetrahydrofuran (THF) from benzophenone sodium ketyl; CH2Cl2 from CaH2; MeOH from 
Mg(OMe)2.  All experiments involving air- and and/or moisture-sensitive compounds were 
conducted in an oven-dried round-bottom flask capped with a rubber septum, and attached via 
a needle and connecting tubing to an argon manifold equipped with mercury bubbler (ca. 5 mm 
positive pressure of argon).  Low temperature baths were: ice/water (0 oC), CO2(s)/water/ice (-
20 oC), and CO2(s)/acetone (-78 
oC).  Unless otherwise noted, reaction temperatures refer to that 
of the bath. 
Concentration refers to removal of volatiles at water aspirator pressure on a rotary 
evaporator.  Preparative TLC (PTLC) was carried out on glass plates (20x20 cm) pre-coated (0.25 
mm) with silica get 60 F254.  Materials were detected by visualization under an ultraviolet lamp 
(254 nm) and/or by treating a 1 cm vertical strip removed from the plate with a solution of 
phophomolybdic acid (5%) containing traces of ceric sulfate in aqueous sulfuric acid (5% v/v) 
followed by charring on a hot plate.  Flash column chromatography (FCC) was performed 
according to Still et al. with silica gel 60 (40-63 µm).28  All mixed solvent eluents are reported as 
v/v solutions.  Unless otherwise noted, all reported compounds were homogeneous by thin 
layer chromatography (TLC) and by 1H NMR.  
4.2. SPECTRAL DATA 
High resolution mass spectra (HRMS) and low resolution mass spectra (LRMS) were 
obtained on a double focusing high resolution spectrometer; only partial data are reported.  EI 
ionization was accomplished at 70 eV and CI ionization at 50 eV with ammonia as the reagent 
gas; only a partial data are reported.  IR spectra were recorded on a Fourier transform 
interferometer using a diffuse reflectrance cell (DRIFT); only diagnostic and/or intense peaks 
are reported.  NMR spectra were measured in CDCl3 solution at 500 MHz or 600 MHz for 
1H and 
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125 MHz or 150 MHz for 13C.  Signals due to the solvent (13C NMR) or residual protonated 
solvent (1H NMR) served as the internal standard: CDCl3 (7.26 δH, 77.23 δC).  The 
1H NMR 
chemical shifts and coupling constants were determined assuming first-order behaviour.  
Multiplicity is indicated by one or more of the following: s (singlet), d (doublet), t (triplet), q 
(quartet), m (multiplet), br (broad), ap (apparent); the list of coupling constants (J) corresponds 
to the order of the multiplicity assignment.  Coupling constants (J) are reported to the nearest 
0.5 Hz (digital resolution ca. 0.2 Hz/pt).  The 1H NMR assignments were made based on 
chemical shift and multiplicity and were confirmed, where necessary, by homonuclear 
decoupling and/or two-dimensional correlation experiments (gCOSY, gHSQC, gHMBC).29  The 
13C NMR assignments were made on the basis of chemical shift and multiplicity (as determined 
by 13C-DEPT or gHSQC) and were confirmed, where necessary, by two-dimensional 1H/13C 
correlation experiments (gHSQC and/or g HMBC).4, 29 
4.3. MATERIALS 
The preparations of the following compounds have been previously described: 179;26 
48;30 15;6 16, 17-SS, 17-AS, 17-SA;7  17-AA;9  17-SA-TES, 17-SA-MOM, 17-AA-TES, 17-AA-MOM, 
17-AS-TES, 17-SS-TES;10  iPr2NEt was distilled from KOH under argon and was stored over KOH.  
CDCl3 was treated with basic Al2O3 before use.  All other reagents were commercially available 
and unless otherwise noted, were used as received.  
4.4. GENERAL EXPERIMENTAL PROCEDURES 
4.4.1. General Procedure for Aldol Reactions of 16 with 15 via Soft 
Enolization 
MgBr2·OEt2 (6 equiv) was added to a stirred solution of aldehyde 15 (1 equiv, 0.03 M in 
CH2Cl2) at room temperature under Ar.  After 10 min, ketone 16 (1 equiv) was added and the 
reaction was cooled to 0 °C over 10 min.  i-Pr2NEt (1 equiv) was added dropwise and the 
reaction mixture was allowed to stir at 0 °C for 10 min and was quenched by the addition of 
                                                          
4
 The multiplicity of the 
13
C NMR signals refers to the number of attached H’s (i.e., s = C, d = CH2, q = CH3) 
72 
 
water with vigorous stirring.  The mixture was diluted with ethyl acetate and transferred to a 
separatory funnel containing saturated Na2CO3 solution with ethyl acetate.  The organic layer 
was removed and the aqueous layer was washed with ethyl acetate.  The combined organic layers 
were dried over Na2SO4 and concentrated to give the crude products.  By addition of a carefully 
measured amount of 1,4-dicyanobenzene, the combined yield of 17 was determined. 
4.4.2. Procedure for Aldol Reactions of 16 with 15 via Soft 
Enolization on 0.5-mmol scale 
MgBr2·OEt2 (6 equiv, 798 mg) was added to a stirred solution of aldehyde 15 (97 mg, 
0.52 mmol, 0.03 M in CH2Cl2) at room temperature under Ar.  After 10 min, ketone 16 (2 equiv, 
121 mg, 1.0 mmol) was added and the reaction was cooled to 0 °C over 15 min. i-Pr2NEt (1 
equiv) was added dropwise over 10 seconds.  The reaction mixture was allowed to stir at 0 °C for 
10 min and then was quenched by addition of 50 mL of ice-cold phosphate buffer (pH 7). The 
mixture was allowed to warm to room temperature with vigorous stirring and was transferred to 
a separatory funnel with CH2Cl2. If the organic layer was not clear, brine was added.  The 
organic layer was removed and the aqueous layer was extracted with CH2Cl2.  The combined 
organic layers were dried over Na2SO4 and concentrated to provide the crude products.  Analysis 
by 
1
H NMR revealed a 39:61:1:0 mixture of 17-AA, 17-SA, 17-AS and 17-SS, respectively in 
addition to 15.  By addition of a carefully measured amount of 1,4-dicyanobenzene, the 
combined yield of 17 was determined to be 65%.  2-5 mL of methanol were added to the crude 
mixture and 69 mg (44%) of insoluble 17-SA was filtered off.  The mother liquor was 
concentrated to give 155 mg of 78:22 17-AA and 17-AS in addition to some bis-aldols 18 and 15 
(17-SA not detected).  Fractionation of the crude by FCC (30% ethyl acetate/hexanes to 100% 
ethyl acetate) gave a 81:18:2 mixture of 17-AA, 17-SA and 17-AS, respectively (43 mg, 27%) 
and 13 mg of bis-aldols 18 (10% based on 15). 
4.4.3. General Procedure for Aldol Reactions of 17 with 15 via Soft 
Enolization 
MgBr2·OEt2 (6 equiv) was added to a stirred solution of aldehyde 15 (1 equiv, 0.03 M in 
CH2Cl2) at room temperature under Ar.  After 10 min, the reaction was cooled to 0 
o
C and the 
ketone 17 (1 equiv) and i-Pr2NEt (1 equiv) were sequentially added. The reaction mixture was 
allowed to stir for 10-30 min and then was quenched by addition of ice-cold phosphate buffer 
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(pH 7). The mixture was allowed to warm to room temperature with vigorous stirring and was 
transferred to a separatory funnel with CH2Cl2. If the organic layer was not clear, brine was 
added. The organic layer was removed and the aqueous layer was extracted with CH2Cl2. The 
combined organic layers were dried over Na2SO4 and concentrated to provide the crude products. 
Analysis by 
1
H NMR revealed a mixture of two aldol adducts in addition to 15 and 17; other 
adducts, if present, were not detected. 
4.4.4. General Procedure for TES deprotection 
A 6 M solution of HF·pyridine was prepared by adding commercial HF·pyridine (70% 
HF, 30% pyridine; 0.19 mL) and pyridine (0.57 mL) to THF (1.0 mL). The above solution was 
added to the TES-containing substrate and the resulting solution was stirred at room temperature 
until the reaction was complete by TLC analysis (4 to 48 h).  The mixture was diluted with a 3:1 
mixture of hexane and CH2Cl2 (v/v), respectively, washed sequentially with saturated aqueous 
NaHCO3 and 2% citric acid solution, dried over Na2SO4, and concentrated to give the crude 
product. 
4.4.5. General Procedure for MOM deprotection 
The following procedure was used without optimization for conversion. TiCl4 (5 equiv) 
was added dropwise over 10 seconds to a stirred solution of substrate in CH2Cl2 (50 mL/ mmol) 
at -78 
o
C under argon.  After 5 minutes, a fine yellow slurry developed.  Thiophenol (10 equiv) 
was added dropwise over 10 seconds and the resultant red-orange fine slurry was stirred for a 
further 10 minutes at -78 
o
C.  MeOH (0.5 mL) was added and the cooling bath bath was removed 
(reaction became colourless upon addition of MeOH).  The solution was stirred vigorously for 1 
minute followed by the addition of phosphate buffer (3 mL, pH 7).  After 3 minutes, the mixture 
was diluted with saturated Na2CO3 and extracted with CH2Cl2 (3x).  The combined organic 
extracts were dried over Na2SO4 and concentrated to give the crude product. 
4.4.6. General Procedure for Reduction with NaBH47 
NaBH4 (2 equiv) was added to a stirred solution of the ketone in ethanol (0.1 M) at rt.  
After 1 h, the reaction was quenched by dropwise addition of aqueous HCl (1 M) until gas 
evolution ceased. The mixture was neutralized by addition of 15% aqueous NaOH and, after 30 
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min, was extracted with ethyl acetate (x3).  The combined organic layers were dried over 
Na2SO4 and concentrated to give the crude product. 
4.4.7. General Procedure for Isomerization8 
The bis-aldol substrate was dissolved in solution of imidazole in CH2Cl2 (0.8 M; ca. 1 
mL/10 mg substrate) and the resulting solution allowed to stand at room temperature. After 
sufficient time to reach equilibrium, the mixture was diluted with citric acid (0.1 M) and 
extracted with CH2Cl2. The combined organic layers were dried over Na2SO4 and concentrated 
to give the crude products. 
4.5. EXPERIMENTAL PROCEDURES AND SPECTRAL DATA FOR 
COMPOUNDS 
(3S,5S)-rel-3-[(S)-(6S)-1,4-Dioxa-8-thiaspiro[4.5]dec-6-yl(triethylsilyloxy)methyl]-5-[(R)-
(6R)-1,4-dioxa-8-thiaspiro[4.5]dec-6-ylhydroxymethyl]tetrahydro-4H-thiopyran-4-one (18-
SA-TES-trans-AA) 
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Following the above General Procedure, reaction of 17-SA-TES (215 mg, 0.514 mmol) 
with 15 (101 mg, 0.538 mmol) for 60 min gave a crude that contained a 25:36:26:13 mixture of 
15, 17-SA-TES, 18-SA-TES-trans-AA, and 18-SA-TES-trans-SA, respectively. Fractionation 
of the crude by FCC (30% ethyl acetate/hexanes) gave 18-SA-TES-trans-AA (23 mg, 7%), and 
a 2:1 mixture of 18-SA-TES-trans-AA and 18-SA-TES-trans-AA, respectively (109 mg, 35%). 
A concentrated (15mg/1mL) solution of 18-SA-TES-trans-AA in acetonitrile when stored in a 
refrigerator (ca. 5 °C) deposited crystals suitable for XRD analysis (see Appendix A for X-ray 
data). 
IR max 3484, 1707 cm
-1
. 
1
H NMR (500 MHz, CDCl3)  5.09 (1H, d, J = 2.5 Hz, HC-1'), 4.37 (1H, ddd, J = 3.5, 5, 7 Hz, 
HC-1''), 4.04-3.88 (6H, m, HCO 6), 3.74 (1H, d, J = 3.5 Hz, HO), 3.80-3.67 (2H, m, HCO 2), 
3.46 (1H, dd, J = 8, 8.5 Hz, HC-3), 3.21 (1H, dd, J = 8, 13.5 Hz, HC-6), 3.05-2.82 (8H, m, H2C-
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2, HC-5, H2C-7', H2C-7'', HC-9'), 2.79 (1H, dd, J = 4, 13.5 Hz, HC-6), 2.75-2.63 (2H, m, HC-9''), 
2.45 (1H, br d, J = 13.5 Hz, HC-9'), 2.26-2.18 (2H, m, HC-6', HC-6''), 2.18-2.11 (1H, m, HC-
10''), 2.01 (1H, ddd, J = 3, 3, 13.5 Hz, HC-10'), 1.80-1.73 (1H, m, HC-10''), 1.69 (1H, ddd, J = 
3.5, 13, 13.5 Hz, HC-10'), 0.93 (9H, t, J = 8 Hz, H3C 3), 0.66-0.59 (6H, m, H2CSi 3). 
13
C NMR (125 MHz, CDCl3)  210.0 (s, C-4), 111.1 (s, C-5''), 108.8 (s, C-5'), 73.9 (s, C-1''), 
65.0 (t, CH2O), 64.6 (d, C-1'), 64.5 (t, CH2O), 64.2 (t, CH2O), 64.0 (t, CH2O), 54.7 (d, C-5 or C-
6'), 54.6 (d, C-5 or C-6'), 52.1 (d, C-3), 46.0 (d, C-6''), 37.7 (t, C-10'), 34.9 (t, C-10''), 30.6 (t, C-
7''), 30.0 (t, C-6), 27.71 (t, C-2 or C-7'), 27.68 (t, C-2 or C-7'), 27.1 (t, C-9'), 26.8 (t, C-9''), 7.2 (q 
3, CH3), 5.2 (t 3, CH2Si). 
LRMS (EI), m/z (relative intensity): 606 ([M]
+
, 0.1), 577 (1), 559 (1), 389 (12), 245 (30), 229 
(36), 171 (27), 132 (41), 99 (100). 
HRMS m/z calcd for C27H46O7S3Si 606.2175, found 606.2178 (EI). 
(3S,5S)-rel-3-[(S)-(6S)-1,4-Dioxa-8-thiaspiro[4.5]dec-6-yl(triethylsilyloxy)methyl]-5-[(S)-
(6S)-1,4-dioxa-8-thiaspiro[4.5]dec-6-ylhydroxymethyl]tetrahydro-4H-thiopyran-4-one (18-
SA-TES-trans-SA) 
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From aldol reaction of 17-SA-TES with 15.  See experimental procedure for compound 
18-SA-TES-trans-AA. 
IR max 3482, 1711 cm
-1
. 
1
H NMR (500 MHz, CDCl3)  5.16 (1H, d, J = 2.5 Hz, HC-1'), 4.65 (1H, br d, J = 9 Hz, HC-1''), 
4.06-3.90 (6H, m, H2CO 6), 3.83 (1H, s, HO), 3.82-3.68 (2H, m, HCO 2), 3.41 (1H, dd, J = 7, 
10 Hz, HC-3), 3.35 (1H, dd, J = 12, 13.5 Hz, HC-6), 3.05 (1H, dd, J = 7, 12.5 Hz, HC-2), 2.98 
(1H, dd, J = 12, 12.5 Hz, HC-2), 2.95-2.81 (3H, m, H2C-7', HC-9'), 2.81-2.70 (3H, m, HC-7'', 
H2C-9''), 2.67 (1H, br dd, J = 5, 12 Hz, HC-5), 2.57 (1H, dd, J = 7.5, 14 Hz, HC-7''), 2.51 (1H, 
dd, J = 5, 13.5 Hz, HC-6), 2.46 (1H, br dd, J = 2, 13.5 Hz, HC-9'), 2.20 (2H, m, HC-10'', HC-7'), 
2.01 (1H, br d, J = 13.5 Hz, HC-10'), 1.93 (1H, ddd, J = 3, 7.5, 9 Hz, HC-6''), 1.83-1.78 (1H, m, 
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HC-10''), 1.70 (1H, ddd, J = 3, 13, 13.5 Hz, HC-10'), 0.93 (9H, t, J = 8 Hz, H3C 3), 0.62 (6H, ap 
q, J = 8 Hz, H2CSi 3). 
13
C NMR (125 MHz, CDCl3)  210.9 (s, C-4), 110.8 (s, C-5''), 108.8 (s, C-5'), 71.7 (d, CH-1''), 
65.0 (t, CH2O), 64.9 (t, CH2O), 64.8 (d, C-1'), 64.3 (t, CH2O), 64.2 (t, CH2O), 54.5 (d, C-6'), 53.5 
(d, CH-5), 51.4 (d, C-3), 46.7 (d, C-6''), 37.8 (t, C-10'), 34.6 (t, C-10''), 29.1 (t, C-7''), 27.6 (t, C-
7'), 27.1 (t, C-9'), 26.8 (t, C-9''), 23.8 (t, C-2), 22.1 (t, C-6), 7.1 (q 3, CH3), 5.20 (t 3, CH2Si). 
LRMS (EI), m/z (relative intensity): 606 ([M]
+
, 0.1), 559 (1), 474 (3.3), 389 (13), 229 (37), 171 
(29), 99 (100). 
HRMS m/z calcd for C27H46O7S3Si 606.2175, found 606.2153 (EI). 
(3S,5S)-rel-3-[(S)-(6S)-1,4-Dioxa-8-thiaspiro[4.5]dec-6-yl(methoxymethoxy)methyl]-5-[(R)-
(6R)-1,4-dioxa-8-thiaspiro[4.5]dec-6-ylhydroxymethyl]tetrahydro-4H-thiopyran-4-one (18-
SA-MOM-trans-AA) 
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The ketone 17-SA-MOM (19 mg, 0.055 mmol) was added to a stirred suspension of i-
Pr2NEt (9 uL, 0.06 mmol), MgBr2·OEt2 (82 mg, 0.32 mmol) and 1 (10 mg, 0.053 mmol) in 
CH2Cl2 (1.8 mL). After 60 min, the reaction was quenched and worked up as described in the 
General Procedure to give a crude that contained a 27:40:22:11 mixture of 15, 17-SA-MOM, 18-
SA-MOM-trans-AA, and 18-SA-MOM-trans-SA, respectively; by addition of a carefully 
measured amount of 1,4-dicyanobenzene, the combined yield of bis-aldol adducts was 
determined to be 25%. The crude products from several similar experiments were combined and 
fractionated by PTLC (5% ethyl acetate, 15% acetone in hexanes, several elutions) to provide 
pure samples of 18-SA-MOM-trans-AA and 18-SA-MOM-trans-SA. A saturated solution of 
18-SA-MOM-trans-SA in acetonitrile when stored in a refrigerator (ca. 5°C) deposited crystals 
suitable for XRD analysis  (see Appendix B for X-ray data). 
IR max 3483, 1707 cm
-1
. 
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1
H NMR (500 MHz, CDCl3)  4.82 (1H, d, J = 6.5 Hz, HCO2), 4.79 (1H, br s, HC-1'), 4.64 (1H, 
d, J = 6.5 Hz, HCO2), 4.36 (1H, ddd, J = 3, 4.5, 7 Hz, HC-1''), 4.02-3.96 (6H, m, H2CO 3), 3.86 
(1H, d, J = 3 Hz, HO), 3.81-3.73 (2H, m, H2CO), 3.54 (1H, ddd, J = 1.5, 6.5, 10.5 Hz, HC-3), 
3.36 (3H, s, H3CO), 3.26 (1H, dd, J = 9, 13.5 Hz, HC-6), 3.11 (1H, dd, J = 7, 13.5 Hz, HC-2), 
3.00-2.79 (7H, m, HC-5, H2C-7', H2C-7'', HC-9', HC-2), 2.79 (1H, dd, J = 5, 13.5 Hz, HC-6), 
2.77-2.62 (2H, m, H2C-9''), 2.52-2.44 (2H, m, HC-6', HC-9'), 2.22 (1H, ddd, J = 3.5, 7, 7.5 Hz, 
HC-6''), 2.14 (1H, ddd, J = 3, 8.5, 13.5 Hz, HC-10''), 2.04 (1H, ddd, J = 3, 3.5, 13.5 Hz, HC-10'), 
1.77 (1H, ddd, J = 3.5, 7.5, 13.5 Hz, HC-10''), 1.72 (1H, ddd, J = 3.5, 13, 13.5 Hz, HC-10'). 
13
C NMR (125 MHz, CDCl3)  211.0 (s, C-4), 111.0 (s, C-5''), 108.8 (s, C-5'), 97.8 (t, OCH2O), 
73.7 (d, C-1''), 72.2 (d, CH-1'), 64.9 (t, CH2O), 64.6 (t, CH2O), 64.1 (t, CH2O), 64.0 (t, CH2O), 
56.2 (d, CH3O), 54.3 (d, C-5), 52 (d, C-3), 51.6 (d, C-6'), 45.9 (d, C-6''), 37.3 (t, C-10'), 34.6 (t, 
C-10''), 30.3 (t, C-7''), 29.6 (t, C-6), 28.5 (t, C-7'), 27.3 (t, C-2), 27.1 (t, C-9'), 26.8 (t, C-9''). 
LRMS (EI), m/z (relative intensity): 536 ([M]
+
, 0.1), 474 (7), 412 (7), 286 (11), 224 (9), 188 
(13), 159 (17), 133 (73), 99 (100). 
HRMS m/z calcd for C23H36O8S3 536.1565, found 536.1567 (EI). 
(3S,5S)-rel-3-[(S)-(6S)-1,4-Dioxa-8-thiaspiro[4.5]dec-6-yl(methoxymethoxy)methyl]-5-[(S)-
(6S)-1,4-dioxa-8-thiaspiro[4.5]dec-6-ylhydroxymethyl]tetrahydro-4H-thiopyran-4-one (18-
SA-MOM-trans-SA) 
S S
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From aldol reaction of 17-SA-MOM with 15.  See experimental procedure for compound 
18-SA-MOM-trans-AA. 
IR max 3482, 1710 cm
-1
. 
1
H NMR (500 MHz, CDCl3)  4.86 (1H, br s, HC-1'), 4.79 (1H, d, J = 6.5 Hz, HCO2), 4.64 (1H, 
br d, J = 3 Hz, HC-1''), 4.63 (1H, d, J = 6.5 Hz, HCO2), 4.12-3.76 (8H, m, H2CO 4), 3.83 (1H, 
br s, HO), 3.46 (1H, dd, J = 7, 9.5 Hz, HC-3), 3.35 (3H, s, H3CO), 3.35 (1H, dd, J = 11.5, 13.5 
Hz, HC-6), 3.11 (1H, dd, J = 7, 12.5 Hz, HC-2), 2.97 (1H, dd, J = 10, 12.5 Hz, HC-2), 2.95-2.68 
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(7H, m, HC-5, H2C-7', HC-7'', H2C-9', HC-9''), 2.57 (1H, dd, J = 7.5, 14 Hz, HC-7''), 2.54 (1H, 
dd, J = 5.5, 13.5 Hz, HC-6), 2.51-2.42 (2H, m, HC-6', HC-9'), 2.20-2.14 (1H, m, HC-10''), 2.03 
(1H, ddd, J = 3, 3.5, 13.5 Hz, HC-10'), 1.93 (1H, ddd, J = 3, 7.5, 8.5 Hz, HC-6''), 1.83-1.76 (1H, 
m, HC-10''), 1.72 (1H, ddd, J = 3.5, 13, 13.5 Hz, HC-10'). 
13
C NMR (125 MHz, CDCl3)  211.3 (s, C-4), 110.7 (s, C-5''), 108.8 (s, C-5'), 97.8 (t, OCH2O), 
72.2 (d, C-1'), 72.0 (d, C-1''), 64.95 (t, CH2O), 64.92 (t, CH2O), 64.26 (t, CH2O), 64.22 (t, 
CH2O), 56.2 (q, CH3O), 53.5 (d, C-5), 51.4 (d, C-6'), 51.2 (d, C-3), 46.5 (d, C-6''), 37.5 (t, C-10'), 
34.5 (t, C-10''), 29.2 (t, C-7''), 28.3 (t, C-7'), 27.1 (t, C-9'), 26.8 (t, C-9''), 24.3 (t, C-2), 22.4 (t, C-
6). 
LRMS (EI), m/z (relative intensity): 518 ([M-18]
+
, 0.1), 348 (1), 286 (9), 188 (9), 159 (9), 132 
(50), 99 (100), 86 (19), 54 (22). 
HRMS m/z calcd for C23H36O8S3 536.1572 (537.1651 for M+H), found 537.1662 (CI, NH3). 
(3R,5R)-rel-3-[(S)-(6S)-1,4-Dioxa-8-thiaspiro[4.5]dec-6-yl(triethylsilyloxy)methyl]-5-[(S)-
(6S)-1,4-dioxa-8-thiaspiro[4.5]dec-6-ylhydroxymethyl]tetrahydro-4H-thiopyran-4-one (18-
AA-TES-trans-AA) 
S S
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Following the above General Procedure, reaction of 17-AA-TES (199 mg, 0.476 mmol) 
with 15 (92 mg, 0.49 mmol) for 60 min gave a crude that contained a 27:21:19:32 mixture of 15, 
17-AA-TES, 18-AA-TES-trans-AA, and 4-AA-TES-trans-SA, respectively. Fractionation of 
the crude by FCC (30% ethyl acetate/hexanes) gave 18-AA-TES-trans-AA (46 mg, 16%), 18-
AA-TES-trans-SA (85 mg, 30%). 
IR max 3505, 1702 cm
-1
. 
1
H NMR (500 MHz, CDCl3)  4.52 (1H, dd, J = 2.5, 4 Hz, HC-1'), 4.16 (1H, ddd, J = 3.5, 4, 7 
Hz, HC-1''), 4.11-3.88 (8H, m, H2CO 4), 3.88 (1H, d, J = 4 Hz, HO), 3.22 (1H, dd, J = 11, 13 
Hz, HC-6), 3.21 (1H, ddd, J = 4, 4.5, 5.5 Hz, HC-3), 3.03 (1H, dd, J = 12, 13.5 Hz, HC-7'), 2.97-
2.78 (7H, m, H2C-2, HC-5, HC-6, HC-7'', HC-9', HC-9''), 2.73-2.61 (2H, m, HC-7', CH-9''), 2.58 
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(1H, dd, J = 7, 14 Hz, HC-7''), 2.51-2.43 (2H, m, HC-6'', HC-9'), 2.26 (1H, ddd, J = 2.5, 3, 12 
Hz, HC-6'), 2.16 (1H, ddd, J = 3.5, 9.5, 13.5 Hz, HC-10''), 2.11 (1H, br d, J = 13.5 Hz, HC-10'), 
1.79 (1H, ddd, J = 3.5, 7, 13.5 Hz, HC-10''), 1.66 (1H, ddd, J = 4, 13, 13.5 Hz, HC-10'), 0.97 
(9H, t, J = 8 Hz, H3C 3), 0.67 (6H, m, H2CSi 3). 
13
C NMR (125 MHz, CDCl3)  209.8 (s, C-4), 110.5 (s, C-5''), 108.9 (s, C-5'), 72.81 (d, C-1' or 
C-1''), 72.77 (d, C-1' or C-1''), 64.9 (t, CH2O), 64.3 (t, CH2O), 64.2 (t, CH2O), 64.1 (t, CH2O), 
53.9 (d, C-3), 53.8 (d, C-6'), 53.5 (d, C-5), 46.1 (d, C-6''), 37.0 (t, C-10'), 34.5 (t, C-10''), 33.6 (t, 
C-2), 32.1 (t, C-6), 30.3 (t, C-7''), 27.9 (t, C-7'), 26.95 (t, C-9' or C-9''), 26.91 (t, C-9' or C-9''), 
7.3 (q 3, CH3), 5.5 (t 3, CH2Si). 
LRMS (CI, NH3), m/z (relative intensity): 607 ([M+1]
+
, 1), 419 (100), 287 (90), 229 (34), 225 
(23), 189 (92), 132 (35), 99 (44). 
HRMS m/z calcd for C27H46O7S3Si 606.2175 (607.2253 for M+H), found 607.2260 (CI, NH3). 
(3R,5R)-rel-3-[(S)-(6S)-1,4-Dioxa-8-thiaspiro[4.5]dec-6-yl(triethylsilyloxy)methyl]-5-[(R)-
(6R)-1,4-dioxa-8-thiaspiro[4.5]dec-6-ylhydroxymethyl]tetrahydro-4H-thiopyran-4-one (18-
AA-TES-trans-SA) 
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From aldol reaction of 17-AA-TES with 15.  See experimental procedure for compound 
18-AA-TES-trans-AA. 
IR max 3501, 1707 cm
-1
. 
1
H NMR (500 MHz, CDCl3)  4.65-4.63 (2H, m, HC-1', HC-1''), 4.09-3.84 (8H, m, H2CO 4), 
3.83 (1H, s, HO), 3.26-3.20 (1H, m, HC-6), 3.18 (1H, ddd, J = 5, 5, 5 Hz, HC-3), 3.00 (1H, dd, J 
= 5, 13.5 Hz, HC-2), 2.98 (1H, dd, J = 12, 14 Hz, HC-7''), 2.87-2.55 (10H, m, HC-2, HC-5, HC-
6, H2C-7', H2C-7'', HC-9', H2C-9''), 2.47 (1H, br d, J = 13.5 Hz, HC-9'), 2.27 (1H, ddd, J = 2, 3, 9 
Hz, HC-6'), 2.17 (1H, ddd, J = 3, 7, 13.5 Hz, HC-10''), 2.11 (1H, ddd, J = 3, 3.5, 13.5 Hz, HC-
10'), 2.00 (1H, ddd, J = 3, 8.5, 9 Hz, HC-6''), 1.81 (1H, ddd, J = 3.5, 9.5, 13.5 Hz, HC-10''), 1.67 
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(1H, ddd, J = 3.5, 13, 13.5 Hz, HC-10'), 0.96 (9H, t, J = 8 Hz, H3C 3), 0.72-0.58 (6H, m, H2CSi 
3). 
13
C NMR (125 MHz, CDCl3)  208.1 (s, C-4), 110.7 (s, C-5''), 108.9 (s, C-5''), 71.9 (d, C-1'), 
68.6 (d, C-1''), 65.0 (t, CH2O), 64.30 (t, CH2O), 64.29 (t, CH2O), 4.0 (t, CH2O), 53.7 (d, C-6'), 
53.5 (d, C-3), 52.9 (d, C-5), 47.6 (d, C-6''), 37.1 (t, C-10'), 35.5 (t, C-10''), 32.6 (t, C-2), 29.1 (t, 
C-7''), 28.0 (t, C-7'), 27.5 (t, C-6), 26.9 (t, C-9'), 26.8 (t, C-9''), 7.2 (q 3, CH3), 5.6 (t 3, CH2Si). 
LRMS (CI, NH3), m/z (relative intensity): 607 ([M+1]
+
, 5), 475 (13), 419 (80), 389 (17), 287 
(95), 229 (44), 189 (100), 99 (71). 
HRMS m/z calcd for C27H46O7S3Si 606.2175 (607.2253 for M+H), found 607.2244 (CI, NH3). 
(3S,5S)-rel-3-[(R)-(6S)-1,4-Dioxa-8-thiaspiro[4.5]dec-6-yl(triethylsilyloxy)methyl]-5-[(R)-
(6R)-1,4-dioxa-8-thiaspiro[4.5]dec-6-ylhydroxymethyl]tetrahydro-4H-thiopyran-4-one (18-
AS-TES-trans-AA) 
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Following the above General Procedure, reaction of 17-AS-TES (120 mg, 0.287 mmol) 
with 15 (60 mg, 0.32 mmol) for 15 min gave a crude that contained a 20:18:32:29 mixture of 15, 
17-AS-TES, 18-SS-TES-trans-AA, and 18-SS-TES-trans-SA, respectively. Fractionation of 
the crude by FCC (30% Ethyl acetate/hexanes) gave 17-AS-TES (35 mg, 29%), and a 1:1.5 
mixture (114 mg, 66%) of 18-AS-TES-trans-AA and 18-AS-TES-trans-SA, respectively. The 
bis-aldol mixture (56 mg) was further fractionated by PTLC (30% ethyl acetate/hexanes, 
multiple elutions) to give 18-AS-TES-trans-AA (34 mg) and 18-AS-TES-trans-AA (20 mg). 
IR max 3493, 1716 cm
-1
. 
1
H NMR (500 MHz, CDCl3)  4.72 (1H, br s, HC-1'), 4.21 (1H, ddd, J = 3, 3, 8 Hz, HC-1''), 
4.01-3.84 (9H, m, HO, H2CO 4), 3.19 (1H, dd, J = 11.5, 14 Hz, HC-6), 3.13 (1H, dd, J = 11, 12 
Hz, HC-2), 2.94-2.74 (8H, m, HC-2, HC-3, HC-5, HC-6, HC-7', H2C-7'', HC-9'), 2.70-2.58 (4H, 
m, HC-7', H2C-9', HC-9''), 2.50 (1H, ddd, J = 3, 7, 7.5 Hz, CH-6''), 2.18-2.07 (3H, m, CH-6', 
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CH-10', CH-10''), 1.82 (1H, ddd, J = 3, 7, 13.5 Hz, CH-10'), 1.56 (1H, ap ddd, J = 4, 8, 13 Hz, 
CH-10''), 0.95 (9H, t, J = 8 Hz, H3C 3), 0.64 (6H, ap q, J = 8 Hz, H2CSi 3). 
13
C NMR (125 MHz, CDCl3)  208.7 (s, C-4), 110.5 (s, C-5''), 109.3 (s, C-5'), 73.3 (d, C-1''), 
68.9 (d, C-1'), 64.8 (t, CH2O), 64.7 (t, CH2O), 64.2 (t, CH2O), 64.0 (t, CH2O), 59.3 (d, C-3), 51.3 
(d, C-5), 47.8 (d, C-6'), 46.4 (d, C-6''), 34.7 (t, C-10'), 34.5 (t, C-10''), 29.7 (t, C-7'), 29.6 (t, C-
7''), 28.5 (t, C-6), 26.92 (t, C-9' or C-9''), 26.91 (t, C-9' or C-9''), 25.5 (br t, C-2), 7.2 (q 3, CH3), 
5.3 (t 3, CH2Si). 
LRMS (EI), m/z (relative intensity): 588 ([M-18]
+
, 0.3), 389 (19), 257 (12), 229 (100), 171 (12), 
143 (11), 132 (33), 99 (70). 
HRMS m/z calcd for C27H46O7S3Si 606.2175 (588.2069 for M-H2O), found 588.1270 (EI). 
(3S,5S)-rel-3-[(R)-(6S)-1,4-Dioxa-8-thiaspiro[4.5]dec-6-yl(triethylsilyloxy)methyl]-5-[(S)-
(6S)-1,4-dioxa-8-thiaspiro[4.5]dec-6-ylhydroxymethyl]tetrahydro-4H-thiopyran-4-one (18-
AS-TES-trans-SA) 
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From aldol reaction of 17-AS-TES with 15.  See experimental procedure for compound 
18-AS-TES-trans-AA. 
IR max 3506, 1712 cm
-1
. 
1
H NMR (500 MHz, CDCl3)  4.71 (1H, br d, J = 8.5 Hz, HC-1'), 4.68 (1H, dd, J = 2, 6 Hz, HC-
1''), 4.06-3.82 (9H, m, HO, H2CO 4), 3.16-3.09 (2H, m, HC-2, HC-6), 2.91-2.86 (3H, m, HC-2, 
HC-3, HC-7'), 2.82-2.76 (4H, m, HC-5, HC-6', HC-7', HC-7''), 2.72-2.65 (3H, m, HC-9', H2C-
9''), 2.62-2.55 (2H, m, HC-7'', HC-9'), 2.18 (2H, m, HC-6', HC-10''), 2.08 (1H, ddd, J = 3, 6.5, 
13.5 Hz, HC-10'), 2.01 (1H, ddd, J = 3, 8, 8.5 Hz, HC-6''), 1.83-1.77 (1H, m, HC-10''), 1.60 (1H, 
ddd, J = 3.5, 10, 13.5 Hz, HC-10'), 0.96 (9H, t, J = 8 Hz, H3C 3), 0.63 (6H, ap q, J = 8 Hz, 
H2CSi 3). 
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13
C NMR (125 MHz, CDCl3)  207.5 (s, C-4), 110.7 (s, C-5''), 109.2 (s, C-5'), 69.09 (d, C-1' or 
C-1''), 69.05 (d, C-1' or C-1''), 64.9 (t, CH2O), 64.5 (t, CH2O), 64.2 (t, CH2O), 63.9 (t, CH2O), 
59.0 (d, C-3), 51.2 (d, C-5), 48.0 (d, C-6''), 46.7 (d, C-6''), 35.1 (t, C-10'), 34.9 (t, C-10''), 29.54 
(t, C-7' or C-7''), 29.47 (t, C-7' or C-7''), 26.82 (t , C-9' or C-9''), 26.80 (t, C-9' or C-9''), 25.1 (t, 
C-2), 23.1 (t, C-6), 7.2 (q 3, CH3), 5.3 (t 3, CH2Si). 
LRMS (EI), m/z (relative intensity): 588 ([M-18]
+
, 0.5), 389 (19), 257 (12), 229 (100), 171 (14), 
143 (12), 132 (36), 99 (91). 
HRMS m/z calcd for C27H46O7S3Si 606.2175 (588.2069 for M-H2O), found 588.2053 (EI). 
(3R,5R)-rel-3-[(R)-(6S)-1,4-Dioxa-8-thiaspiro[4.5]dec-6-yl(triethylsilyloxy)methyl]-5-[(S)-
(6S)-1,4-dioxa-8-thiaspiro[4.5]dec-6-ylhydroxymethyl]tetrahydro-4H-thiopyran-4-one (18-
SS-TES-trans-AA) 
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Following the above General Procedure, reaction of 17-SS-TES (116 mg, 0.277 mmol) 
with 1 (52 mg, 0.276 mmol) for 30 min gave a crude that contained a mixture of 15, 17-SS-TES, 
18-SS-TES-trans-AA, and 18-SS-TES-trans-SA (signals overlap). Fractionation of the crude 
by FCC (30% ethyl acetate/hexanes) gave 18-SS-TES-trans-AA (10 mg, 6%), 18-SS-TES-
trans-SA (24 mg, 14%), and a 0.3:1.0 mixture of 18-SS-TES-trans-AA and 18-SS-TES-trans-
SA (31 mg, 17%), respectively. 
IR max 3494, 1706 cm
-1
. 
1
H NMR (500 MHz, CDCl3)  4.68 (1H, dd, J = 3.5, 6.5 Hz, HC-1'), 4.36 (1H, ddd, J = 3.5, 4, 8 
Hz, HC-1''), 4.09-3.86 (9H, m, HO, H2CO 4), 3.22-3.15 (2H, m, HC-3, HC-6), 3.02-2.95 (2H, 
m, H2C-2), 2.95-2.87 (2H, m, HC-5, HC-7''), 2.85-2.65 (7H, m, HC-6, H2C-7', HC-7'', HC-9', 
H2C-9''), 2.47 (1H, ddd, J = 3, 3.5, 13.5 Hz, HC-9'), 2.28 (1H, ddd, J = 3, 7, 8 Hz, HC-6''), 2.17 
(1H, ddd, J = 3.5, 8.5, 14 Hz, HC-10''), 2.06-1.98 (2H, m, HC-6', HC-10'), 1.79 (1H, ddd, J = 
3.5, 7.5, 13.5 Hz, HC-10''), 1.63 (1H, ddd, J = 3.5, 13, 13.5 Hz, HC-10'), 0.94 (9H, t, J = 8 Hz, 
H3C 3), 0.70-0.57 (6H, m, H2CSi 3). 
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13
C NMR (125 MHz, CDCl3)  210.4 (s, C-4), 110.8 (s, C-5''), 109.4 (s, C-5'), 73.4 (d, C-1''), 
66.4 (d, C-1'), 64.71 (t, CH2O), 64.66 (t, CH2O), 64.6 (t, CH2O), 64.1 (t, CH2O), 57.4 (d, C-3), 
54.4 (d, C-5), 49.5 (d, C-6'), 46.2 (d, C-6''), 36.7 (t, C-10'), 34.7 (t, C-10''), 31.1 (t, C-6), 30.3 (t, 
C-7''), 28.9 (t, C-7'), 27.3 (t, C-2), 26.8 (t, C-9''), 26.7 (t, C-9'), 7.3 (q 3, CH3), 5.4 (t 3, CH2Si). 
LRMS (EI), m/z (relative intensity): 588 ([M-18]
+
, 0.02), 389 (36), 257 (16), 229 (66), 191 (22), 
143 (34), 132 (43), 103 (20), 99 (100). 
HRMS m/z calcd for C27H46O7S3Si 606.2175 (588.2069 for M-H2O), found 588.2089 (EI). 
(3R,5R)-rel-3-[(R)-(6S)-1,4-Dioxa-8-thiaspiro[4.5]dec-6-yl(triethylsilyloxy)methyl]-5-[(R)-
(6R)-1,4-dioxa-8-thiaspiro[4.5]dec-6-ylhydroxymethyl]tetrahydro-4H-thiopyran-4-one (18-
SS-TES-trans-SA) 
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From aldol reaction of 17-SS-TES with 15.  See experimental procedure for compound 
18-SS-TES-trans-AA. 
IR max 3489, 1710 cm
-1
. 
1
H NMR (500 MHz, CDCl3)  4.72-4.69 (2H, , HC-1', HC-1''), 4.06-3.84 (9H, m, HO, H2CO 
4), 3.30 (1H, dd, J = 11, 13.5 Hz, HC-6), 3.19 (1H, ddd, J = 2, 7.5, 9 Hz, HC-3), 3.05-2.96 (2H, 
m, H2C-2), 2.82-2.65 (H, m, HC-5, H2C-7', HC-7'', HC-9', H2C-9''), 2.57 (2H, dd, J = 5.5, 13.5 
Hz, HC-6, HC-7''), 2.49 (1H, br d, J = 13.5 Hz, HC-9'), 2.23-2.17 (1H, m, HC-10'), 2.05 (1H, 
ddd, J = 4, 7.5, 11 Hz, HC-6'), 1.99 (1H, ddd, J = 3, 4, 13.5 Hz, HC-10''), 1.94 (1H, ddd, J = 3, 
7.5, 8.5 Hz, HC-6''), 1.83-1.77 (1H, m, HC-10'), 1.66 (1H, ddd, J = 4, 13, 13 Hz, HC-10''), 0.92 
(9H, ap t, J = 8 Hz, H3C 3), 0.68-0.57 (6H, m, H2CSi 3). 
13
C NMR (125 MHz, CDCl3)  210.7 (s, C-4), 110.7 (s, C-5''), 109.5 (s, C-5'), 70.6 (d, C-1''), 
66.8 (d, C-1'), 64.90 (t, CH2O), 64.85 (t, CH2O), 64.7 (t, CH2O), 64.2 (t, CH2O), 56.5 (d, C-3), 
53.6 (d, C-5), 49.5 (d, C-6'), 46.4 (d, C-6''), 36.7 (t, C-10'), 34.7 (t, C-10''), 29.4 (t, C-7''), 29.2 (t, 
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C-7'), 26.8 (t, C-9''), 26.7 (t, C-9'), 23.6 (t, C-2 or C-6), 23.5 (t, C-2 or C-6), 7.3 (q 3, CH3), 5.4 
(t 3, CH2Si). 
LRMS (EI), m/z (relative intensity): 577 ([M-29]
+
, 0.6), 389 (37), 257 (17), 229 (69), 201 (18), 
191 (24), 143 (35), 132 (42), 99 (100). 
HRMS m/z calcd for C27H46O7S3Si 606.2175 (577.1784 for M-C2H5), found 577.1798 (EI). 
(3S,5S)-rel-3,5-Bis[(S)-(6S)-1,4-Dioxa-8-thiaspiro[4.5]dec-6-ylhydroxmethyl]tetrahydro-4H-
thiopyran-4-one (18-SA-trans-SA) 
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Following the General Procedure for MOM deprotection, 18-SA-MOM-trans-SA (9 mg, 
0.017 mmol) gave the titled compound (3 mg , 35%) and recovered 18-SA-MOM-trans-SA (5 
mg, 55%) after fractionation by PTLC (80% Ethyl acetate/hexanes). Following the General 
Procedure for TES deprotection, treatment of 18-SA-TES-trans-SA (7 mg, 0.012 mmol) with 
HF·pyridine/THF (0.40 mL) for 48 h gave the titled compound (5 mg , 90%) after fractionation 
by PTLC (30% Ethyl acetate/hexanes). 
IR max 3483, 1708 cm
-1
. 
1
H NMR (500 MHz, CDCl3)  4.63 (2H, br d, J = 8 Hz, HC-1'/HC-1''), 4.07-3.95 (8H, m, H2CO 
4), 3.86 (2H, br s, HO), 3.24 (2H, dd, J = 10.5, 13 Hz, HC-2/HC-6), 2.94 (2H, ddd, J = 3, 6, 
10.5 Hz, HC-3/HC-5), 2.88 (2H, dd, J = 6, 13 Hz, HC-2/HC-6), 2.80-2.67 (6H, m, HC-7'/7'', 
H2C-9'/9''), 2.63 (2H, dd, J = 8, 14 Hz, HC-7'/7''), 2.18 (2H, dd, J = 3.5, 7.5, 13.5 Hz, HC-
10'/10''), 2.02 (2H, ddd, J = 3.5, 8, 8 Hz, HC-6', HC-6''), 1.80 (2H, ddd, J = 3.5, 8.5, 13.5 Hz, 
HC-10', HC-10''). 
13
C NMR (125 MHz, CDCl3)  211.7 (s, C-4), 110.6 (s 2, C-5'/5''), 70.2 (d 2, C-1'/1''), 64.9 (t 
2, CH2O), 64.2 (t 2, CH2O), 52.9 (d 2, C-3/5), 47.3 (d 2, C-6'/6''), 35.2 (t 2, C-10'/10''), 
29.5 (t 2, C-7'/7''), 26.8 (t 2, C-9'/9''), 24.7 (t 2, C-2/6). 
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LRMS (EI), m/z (relative intensity): 474 ([M-18]
+
, 0.3), 456 (2), 304 (5), 188 (11), 159 (5), 132 
(68), 115 (6), 99 (100). 
HRMS m/z calcd for C21H32O7S3 492.1310 (474.1205 for M-H2O), found 474.1196 (EI). 
(3S,5S)-rel-3,5-Bis[(S)-(6S)-1,4-dioxa-8-thiaspiro[4.5]dec-6-ylhydroxymethyl]tetrahydro-
2H-thiopyran-4-ol (190) 
S S
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OO
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Following the General Procedure for the NaBH4, reduction of 18-SA-trans-SA (18 mg, 
0.037 mmol) gave the titled compound 190 (8 mg, 40%) as a colourless solid after fractionation 
by PTLC (ethyl acetate). 
IR max 3455 cm
-1
. 
1
H NMR (500 MHz, CDCl3)  4.42 (1H, s, HOC-4), 4.39 (1H, s, HO-C-1''), 4.34-4.31 (2H, m, 
HC-1', HC-1''), 4.17 (1H, br s, HC-4), 4.07-3.97 (8H, m, H2CO 4), 3.79 (1H, d, J = 5 Hz, HOC-
1'), 3.21 (1H, dd, J = 12, 12.5 Hz, HC-6), 3.12 (1H, dd, J = 4, 13.5 Hz, HC-2), 2.93 (1H, dd, J = 
8.5, 14 Hz, HC-7'), 2.88-2.80 (2H, m, HC-7', HC-7''), 2.79-2.63 (5H, m, HC-2, H2C-9', H2C-9''), 
2.60 (1H, dd, J = 7, 14 Hz, HC-7''), 2.24-2.05 (6H, m, HC-3, HC-5, HC-6, HC-6'', HC-10', HC-
10''), 2.01 (1H, ddd, J = 3, 6.5, 9 Hz, HC-6'), 1.83 (1H, ddd, J = 3.5, 7, 13.5 Hz, HC-10''), 1.79 
(1H, ddd, J = 3.5, 9.5, 13.5 Hz, HC-10'). 
13
C NMR (125 MHz, CDCl3)  111.2 (s, C-5'), 110.9 (s, C-5''), 76.0 (d, C-1''), 73.4 (d, C-4), 
72.5 (d, C-1' ), 64.9 (t, CH2O), 64.4 (t, CH2O), 64.3 (t, CH2O), 64.1 (t, CH2O), 46.23 (d, C-6'), 
46.16 (d, C-6'), 44.9 (d, C-3), 38.4 (d, C-5), 35.7 (t, C-10'), 34.3 (t, C-10''), 31.3 (t, C-7'), 29.2 (t, 
C-7''), 26.9 (t, C-9' or C-9''), 26.8 (t, C-9' or C-9''), 23.4 (t, C-2), 20.0 (t, C-6). 
LRMS (EI), m/z (relative intensity): 494 ([M]
+
, 36), 476 (27), 458 (52), 432 (23), 414 (32), 273 
(25), 132 (53), 99 (100). 
HRMS m/z calcd for C21H34O7S3 494.1467, found 494.1459 (EI). 
86 
 
(3R,5R)-rel-3,5-Bis[(S)-(6S)-1,4-Dioxa-8-thiaspiro[4.5]dec-6-ylhydroxymethyl]tetrahydro-
4H-thiopyran-4-one (18-AA-trans-AA) 
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Following the General Procedure for TES deprotection, treatment of 18-AA-TES-trans-
AA (46 mg, 0.076 mmol) with HF·pyridine/THF (0.83 mL) for 21 h gave the titled compound 
(44 mg, quantitative yield) as a colourless solid  after fractionation by FCC (30-50% ethyl 
acetate/hexane). 
IR max 3487, 1708 cm
-1
. 
1
H NMR (500 MHz, CDCl3)  4.24 (2H, ddd, J = 3, 3.5, 8 Hz, HC-1'/HC-1''), 4.08-3.94 (10H, 
m, H2CO 4, HO 2), 3.27 (2H, dd, J = 10, 13 Hz, HC-2/HC-6), 3.08 (2H, ddd, J = 3.5, 5.5, 10 
Hz, HC-3/HC-5), 2.96 (2H, dd, J = 3, 14 Hz, HC-7'/HC-7''), 2.91 (2H, dd, J = 5.5, 13 Hz, HC-
2/HC-6), 2.80-2.73 (4H, m, HC-7'/HC-7'', HC-9'/HC-9''), 2.68-2.64 (2H, m, HC-9'/HC-9''), 2.34 
(2H, ddd, J = 3, 7, 8 Hz, HC-6'/HC-6''), 2.15 (2H, ddd, J = 3.5, 9, 13.5 Hz, HC-10'/HC-10''), 1.80 
(2H, ddd, J = 3, 7, 13.5 Hz, HC-10'/HC-10''). 
13
C NMR (125 MHz, CDCl3)  212.0 (s, C-4), 110.7 (s 2, C-5'/5'), 72.7 (d 2, C-1'/1''), 64.9 (t 
2, CH2O), 64.2 (t 2, CH2O), 52.8 (d 2, C-3/5), 46.6 (d 2, C-6'/6''), 34.5 (t 2, C-10'/10''), 
30.5 (t 2, C-2/6), 29.7 (t 2, C-7'/7''), 26.9 (t 2, C-9'/9''). 
LRMS (EI), m/z (relative intensity): 492 ([M]
+
, 0.1), 474 (0.7), 456 (0.3), 304 (13), 286 (10), 
188 (31), 159 (24), 132 (100), 99 (81). 
HRMS m/z calcd for C21H32O7S3 492.1310, found 492.1317 (EI). 
(3R,5R)-rel-3,5-Bis[(S)-(6S)-1,4-dioxa-8-thiaspiro[4.5]dec-6-ylhydroxymethyl]-tetrahydro-
2H-thiopyran-4-ol (191) 
S S
OO
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Following the General Procedure for the NaBH4, reduction of 18-AA-trans-AA (22 mg, 
0.045 mmol) gave the titled compound 191 (20 mg, 89%) as a colourless solid after fractionation 
by FCC (75% ethyl acetate in hexanes). 
IR max 3440 cm
-1
. 
1
H NMR (500 MHz, CDCl3)  4.77 (1H, d, J = 1 Hz, HO), 4.47 (1H, br d, J = 2.5 Hz, HO), 4.45 
(1H, s), 4.33 (1H, ddd, J = 4.5, 5, 8 Hz), 4.24 (1H, dd, J = 2, 9 Hz), 4.05-3.96 (8H, m, H2CO 4), 
3.73 (1H, d, J = 4.5 Hz, HO), 3.38 (1H, dd, J = 12.5, 12.5 Hz), 3.29-3.27 (1H, m), 3.01 (1H, dd, 
J = 3, 14 Hz), 2.93-2.64 (8H, m), 2.30-2.12 (8H, m), 1.83 (1H, ddd, J = 4, 7.5, 13.5 Hz), 1.76 
(1H, ddd, J = 4, 8.5, 13.5 Hz). 
13
C NMR (125 MHz, CDCl3)  111.2 (s), 111.1 (s), 76.2 (d), 73.0 (d), 66.4 (d), 64.9 (t), 64.4 (t), 
64.2 (t), 64.0 (t), 47.1 (d), 46.4 (d), 43.7 (d), 37.0 (d), 35.6 (t), 34.5 (t), 31.2 (t), 28.3 (t), 26.9 (t), 
26.7 (t), 25.9 (t), 25.8 (t). 
LRMS (EI), m/z (relative intensity): 494 ([M]
+
, 12), 476 (7), 458 (17), 273 (19), 189 (14), 161 
(21), 132 (72), 99 (100). 
HRMS m/z calcd for C21H34O7S3 494.1467, found 494.1473 (EI). 
(3R,5R)-rel-3-[(S)-(6S)-1,4-Dioxa-8-thiaspiro[4.5]dec-6-ylhydroxymethyl]-5-[(R)-(6R)-1,4-
dioxa-8-thiaspiro[4.5]dec-6-ylhydroxymethyl]tetrahydro-4H-thiopyran-4-one (18-AA-
trans-SA) 
S S
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S
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Following the General Procedure for MOM deprotection, 18-SA-MOM-trans-AA (11 
mg, 0.0205 mmol) gave the titled compound (6 mg, 55%) and recovered 18-SA-MOM-trans-
AA (4 mg, 40%) after fractionation by PTLC (80% Ethyl acetate/hexanes). Following the 
General Procedure for TES deprotection, treatment of 18-AA-TES-trans-SA (39 mg, 0.064 
mmol) with HF·pyridine/THF (0.81 mL) for 21 h gave the titled compound (22 mg, 68%) after 
fractionation by PTLC (75% Ethyl acetate/hexanes). Similar treatment of 18-SA-TES-trans-AA 
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(64 mg, 0.11 mmol) with HF·pyridine/THF (1.0 mL) for 48 h gave the titled compound (37 mg, 
71%) after fractionation by PTLC (75% Ethyl acetate/hexanes). 
IR max 3480, 1708 cm
-1
. 
1
H NMR (500 MHz, CDCl3)  4.59 (1H, br dd, J = 2, 8.5 Hz, HC-1''), 4.26 (1H, ddd, J = 3, 3.5, 
8 Hz, HC-1'), 4.09-3.97 (8H, m, H2CO 4), 3.96 (1H, s, HOC-1'), 3.88 (1H, d, J = 3 Hz, HOC-
1''), 3.28-3.23 (2H, m, HC-2, HC-6), 3.09 (1H, ddd, J = 3.5, 6, 9.5 Hz, HC-3), 2.99 (1H, dd, J = 
6, 12.5 Hz, HC-2), 2.96 (1H, dd, J = 3, 14 Hz, HC-7'), 2.93-2.89 (1H, m, HC-5), 2.82-2.64 (7H, 
m, HC-6. HC-7', HC-7'', H2C-9', H2C-9''), 2.60 (1H, dd, J = 8, 14 Hz, HC-7''), 2.36 (1H, ddd, J = 
3, 7, 8 Hz, HC-6'), 2.20-2.13 (2H, m, HC-10', HC-10''), 2.00 (1H, ddd, J = 3, 8.5, 8.5 Hz, HC-
6''), 1.82-1.77 (2H, m, HC-10', HC-10''). 
13
C NMR (125 MHz, CDCl3)  212.1 (s, C-4), 110.6 (s 2, C-5', C-5'''), 72.6 (d, C-1'), 70.4 (d, 
C-1''), 64.89 (t, CH2O), 64.84 (t, CH2O), 64.23 (t, CH2O), 64.22 (t, CH2O), 53.6 (d, C-5), 51.6 (d, 
C-3), 47.3 (d, C-6''), 46.1 (d, C-6'), 35.1 (t, C-10''), 34.3 (t, C-10'), 29.9 (t, C-7'), 29.4 (t, C-7''), 
28.9 (t, C-2), 27.0 (t, C-9'), 26.8 (t, C-9''), 25.0 (t, C-6). 
LRMS (EI), m/z (relative intensity): 492 ([M]
+
, 0.1), 474 (0.3), 456 (0.8), 188 (14), 159 (5), 132 
(32), 99 (100), 86 (27). 
HRMS m/z calcd for C21H32O7S3 492.1310, found 492.1304 (EI). 
(3S,5R)-rel-3-[(S)-(6S)-1,4-Dioxa-8-thiaspiro[4.5]dec-6-ylhydroxmethyl]-5-[(R)-(6R)-1,4-
dioxa-8-thiaspiro[4.5]dec-6-ylhydroxymethyl]tetrahydro-4H-thiopyran-4-one (18-SA-cis-
SA) 
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Isomerization of 18-AA-trans-SA (16 mg, 0.033 mmol) for 3 d according to the general 
procedure gave a 46:43:11 mixture (by 
1
H NMR) of 18-AA-trans-SA, 18-SA-cis-SA, and 18-
AA-cis-AA, respectively (14 mg), after work up.  Fractionation by PTLC (ethyl acetate; multiple 
elutions) gave 18-AA-trans-SA (6 mg, 37%), and a 5:1 mixture of 18-SA-cis-SA and 18-AA-
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cis-AA, respectively (7 mg, 47%).  The latter mixture was fractionated by PTLC (2% MeOH in 
CH2Cl2; multiple elutions) to give 18-SA-cis-SA (4 mg, 23%) and 18-AA-cis-AA (2 mg, 13%). 
IR max 3489, 1702 cm
-1
. 
1
H NMR (500 MHz, CDCl3)  4.50 (2H, ?, HC-1'/HC-1''), 4.08-3.98 (8H, m, H2CO 4), 3.85 
(2H, d, J = 2.5 Hz, HO 2), 3.09-2.98 (4H, m, HC2-2/H2C-6), 2.92 (2H, ap ddd, J = 5, 5, 12 Hz, 
HC-3/HC-5), 2.75 (2H, ddd, J = 3, 9.5, 13.5 Hz, HC-9'/HC-9''), 2.75-2.67 (4H, m, H2C-7'/H2C-
7''), 2.64 (2H, ap ddd, J = 3.5, 6.5, 13.5 Hz, HC-9'/HC-9''), 2.19-2.12 (4H, m, HC-6'/HC-6'', HC-
10'/HC-10''), 1.77 (2H, ddd, J = 3.5, 9.5, 13.5 Hz, HC-10', HC-10''). 
13
C NMR (125 MHz, CDCl3)  210.5 (s, C-4), 110.9 (s 2, C-5'/5''), 70.8 (d 2, C-1'/1''), 64.7 (t 
2, CH2O), 64.1 (t 2, CH2O), 56.9 (d 2, C-3/5), 46.9 (d 2, C-6'/6''), 35.5 (t 2, C-10'/10''), 
31.8 (t 2, C-2/6), 30.1 (t 2, C-7'/7''), 26.7 (t 2, C-9'/9''). 
LRMS (EI), m/z (relative intensity): 492 ([M]
+
, 0.2), 474 (1), 456 (5), 304 (3), 286 (9), 188 (10), 
132 (77), 99 (100). 
HRMS m/z calcd for C21H32O7S3 492.1310, found 492.1301 (EI). 
(3R,5S)-rel-3-[(S)-(6S)-1,4-Dioxa-8-thiaspiro[4.5]dec-6-ylhydroxmethyl]-5-[(R)-(6R)-1,4-
dioxa-8-thiaspiro[4.5]dec-6-ylhydroxymethyl]tetrahydro-4H-thiopyran-4-one (18-AA-cis-
AA) 
S S
OO
OOH
S
OO
HO
2' 3' 3'' 2''
10''
9''7''
6''
1''
6
5
2
3
1'
6'
7'9'
10'
 
From the isomerization of 18-AA-trans-SA.  See experimental procedure for compound 
18-SA-cis-SA. 
IR max 3493, 1704 cm
-1
. 
1
H NMR (600 MHz, CDCl3)  4.12 (2H, ddd, J = 3, 4, 7.5 Hz, HC-1', HC-1''), 4.07-3.93 (8H, m, 
H2CO 4), 3.83 (2H, d, J = 4 Hz, HO 2), 3.20 (2H, dd, J = 13.5, 14 Hz, HC-2/HC-6), 2.89-2.85 
(4H, m, HC-2/HC-6, HC-3/HC-5), 2.76-2.58 (6H, m, HC-7'/HC-7'', H2C-9'/H2C-9''), 2.48 (2H, 
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dd, J = 7.5, 13.5 Hz, HC-7'/HC-7''), 2.43 (2H, ddd, J = 3, 7.5, 7.5 Hz, HC-6'/HC-6''), 2.12 (2H, 
ddd, J = 3.5, 8.5, 13.5 Hz, HC-10'/10''), 1.75 (2H, ddd, J = 3.5, 8, 13.5 Hz, HC-10'/10''). 
13
C NMR (150 MHz, CDCl3)  210.4 (s, C-4), 110.3 (s 2, C-5'/5''), 72.4 (d 2, C-1'/1''), 64.6 (t 
2, CH2O), 64.1 (t 2, CH2O), 56.2 (d 2, C-3/5), 46.6 (d 2, C-6'/6''), 34.6 (t 2, C-10'/10''), 
34.4 (t 2, C-2/6), 30.1 (t 2, C-7'/7), 26.7 (t 2, C-9'/9''). 
LRMS (EI), m/z (relative intensity): 474 (M-18
+
, 0.4). 
HRMS m/z calcd for C21H32O7S3 492.1310 (474.1205 for M-H2O), found 474.1209 (EI). 
(3R,5S)-rel-3,5-Bis[(S)-(6S)-1,4-Dioxa-8-thiaspiro[4.5]dec-6-ylhydroxmethyl]tetrahydro-
4H-thiopyran-4-one (18-AA-cis-SA) 
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Isomerization of 18-AA-trans-AA (12mg, 0.024 mmol) for 3 d according to the general 
procedure gave a 46:29:25 mixture (by 
1
H NMR) of 18-AA-cis-SA, 18-SA-trans-SA, and 18-
AA-trans-AA, respectively (12 mg), after work up. Fractionation by PTLC (75% ethyl acetate in 
hexane; multiple elutions) gave a mixture of 18-SA-trans-SA and 18-AA-trans-AA (6 mg, 
50%) and 18-AA-cis-SA (6 mg, 50%). 
IR max 3491, 1705 cm
-1
. 
1
H NMR (500 MHz, CDCl3)  4.37 (1H, ddd, J = 4, 5, 6 Hz, HC-1''), 4.15 (1H, ddd, J = 3, 4, 8 
Hz, HC-1'), 4.10-3.95 (8H, m, H2CO 4), 3.84 (1H, d, J = 4 Hz, HOC-1'), 3.69 (1H, d, J = 4 Hz, 
HOC-1''), 3.30 (1H, dd, J = 13, 14 Hz, HC-2), 3.06-2.98 (2H, m, H2C-6), 2.95-2.89 (3H, m, HC-
2, HC-3, HC-5), 2.85-2.60 (7H, m, HC-7', H2C-7'', H2C-9', H2C-9''), 2.55 (1H, dd, J = 7, 14 Hz, 
HC-7'), 2.49 (1H, ddd, J = 3, 7, 8 Hz, HC-6'), 2.24-2.13 (3H, m, HC-6'', HC-10', HC-10''), 1.80 
(1H, ddd, J = 3.5, 7.5, 13.5 Hz, HC-10'), 1.74 (1H, ddd, J = 3.5, 9.5, 13.5 Hz, HC-10''). 
13
C NMR (125 MHz, CDCl3)  210.5 (s, C-4), 111.1 (s, C-5''), 110.4 (s, C-5'), 72.9 (d, C-1'), 
71.0 (d, C-1''), 64.9 (t, CH2O), 64.5 (t, CH2O), 64.3 (t, CH2O), 63.8 (t, CH2O), 57.8 (d, C-5), 55.6 
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(d, C-3), 46.6 (d, C-6'), 45.8 (d, C-6''), 35.3 (t, C-10''), 34.9 (t, C-2), 34.7 (t, C-10'), 32.2 (t, C-6), 
30.3 (t, C-7''), 30.0 (t, C-7'), 26.9 (t, C-9'), 26.7 (t, C-9''). 
LRMS (EI), m/z (relative intensity): 492 ([M]
+
, 0.1), 474 (0.4), 456 (0.7), 304 (6), 286 (7), 188 
(15), 132 (74), 99 (100). 
HRMS m/z calcd for C21H32O7S3 492.1310, found 492.1319 (EI). 
(3S,5S)-rel-3-[(S)-(6R)-1,4-Dioxa-8-thiaspiro[4.5]dec-6-ylhydroxymethyl]-5-[(R)-(6R)-1,4-
dioxa-8-thiaspiro[4.5]dec-6-ylhydroxymethyl]tetrahydro-4H-thiopyran-4-one (18-AS-trans-
AA) 
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Following the General Procedure for TES deprotection, treatment of 18-AS-TES-trans-
SA (10 mg, 0.017 mmol) with HF·pyridine/THF (0.50 mL) for 24 h gave the titled compound (9 
mg, quantitative yield). 
(3S,5S)-rel-3-[(S)-(6R)-1,4-Dioxa-8-thiaspiro[4.5]dec-6-ylhydroxymethyl]-5-[(S)-(6S)-1,4-
dioxa-8-thiaspiro[4.5]dec-6-ylhydroxymethyl]tetrahydro-4H-thiopyran-4-one (18-AS-trans-
AA) 
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Following the General Procedure for TES deprotection, treatment of 18-AS-TES-trans-
AA (5 mg, 0.0083 mmol) with HF·pyridine/THF (0.25 mL) for 24 h gave the titled compound (6 
mg, quantitative yield). 
(3R,5R)-rel-3-[(S)-(6R)-1,4-Dioxa-8-thiaspiro[4.5]dec-6-ylhydroxymethyl]-5-[(S)-(6S)-1,4-
dioxa-8-thiaspiro[4.5]dec-6-ylhydroxymethyl]tetrahydro-4H-thiopyran-4-one (18-SS-trans-
SA) 
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Following the General Procedure for TES deprotection, treatment of 18-SS-TES-trans-
SA (24 mg, 0.040 mmol) with HF·pyridine/THF (0.60 mL) for 24 h gave the titled compound 
(19 mg, quantitative yield). 
(3R,5R)-rel-3-[(S)-(6R)-1,4-Dioxa-8-thiaspiro[4.5]dec-6-ylhydroxymethyl]-5-[(R)-(6R)-1,4-
dioxa-8-thiaspiro[4.5]dec-6-ylhydroxymethyl]tetrahydro-4H-thiopyran-4-one (18-SS-trans-
AA) 
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Following the General Procedure for TES deprotection, treatment of 18-SS-TES-trans-
AA (10 mg, 0.017 mmol) with HF·pyridine/THF (0.50 mL) for 4 h gave the titled compound (8 
mg, quantitative yield). 
 
3-(4-hydroxytetrahydro-4H-thiopyran-4-yl)tetrahydro-4H-thiopyran-4-one 
S
O S
OH
 
MgBr2·OEt2 (2 equiv) was added to a stirred solution of thiopyranone 16 (1 equiv, 121 
mg, 1.04 mmol, 0.3 M in CH2Cl2) at room temperature under Ar.  After 10 min, i-Pr2NEt (1 
equiv) was added.  The reaction mixture was allowed to stir for 10 min and then was quenched 
by the addition of water with vigorous stirring.  The mixture was diluted with ethyl acetate and 
transferred to a separatory funnel containing saturated Na2CO3 solution with ethyl acetate.  The 
organic layer was removed and the aqueous layer was washed with ethyl acetate.  The combined 
organic layers were dried over Na2SO4 and concentrated to give the crude products.  Analysis by 
1
H NMR revealed a 1:13 ratio of 16 and 182, respectively (93% conv.).  Fractionation of the 
crude by FCC (10% ethyl acetate/hexanes) gave 182 (110 mg, 91%). 
IR (DRIFT) max: 3503, 1696, 1424, 1279 cm-1. 
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1H NMR (500 MHz, CDCl3) : 3.65 (1H, br s, HO), 3.12-2.85 (6H, m, H2C-2, HC-2', H2C-6, 
HC-6'), 2.75-2.68 (3H, m, HC-3, H2C-5), 2.38-2.30 (2H, m, HC-2', HC-6'), 2.04 (1H, br d, J = 
13.5 Hz) and 1.94 (1H, br d, J = 13.5 Hz) (HC-3', HC-5'), 1.74 (1H, ddd, J = 2.5, 12, 13.5 Hz) 
and 1.59 (1H, ddd, J = 3, 12.5, 13.5 Hz) (HC-3', HC-5'). 
13C NMR (125 MHz, CDCl3) : 213.1 (C-4), 71.2 (C-4'), 61.8 (C-3), 46.0 (C-5), 37.1 (C-3' or 
C-5'), 34.7 (C-3' or C-5'), 31.4 (C-2 or C-4), 30.9 (C-2 or C-6), 23.6 (C-2' or C-6'), 23.5 (C-2' or 
C-6'). 
LRMS (CI, NH3), m/z (relative intensity): 250 ([M+18]+, 15), 233 ([M+1]+, 100), 215 (32), 116 
(14). 
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6. APPENDIX
Appendix A. Crystallographic data for 18-SA-TES-trans-AA  
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Figure A-1.  ORTEP plot of 18-SA-TES-trans-AA. 
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Table A-1. Crystal data and structure refinement for 18-SA-TES-trans-AA. 
Empirical formula  C27.86 H47.29 N0.43 O7 S3 Si  
Formula weight  624.56  
Temperature  173(2) K  
Wavelength  1.54184 Å  
Crystal system  Monoclinic  
Space group  P 21/n  
Unit cell dimensions a = 14.0686(7) Å = 90°. 
 b = 10.7894(5) Å = 107.6905(15)°. 
 c = 22.0341(11) Å  = 90°. 
Volume 3186.4(3) Å3  
Z 4  
Density (calculated) 1.302 Mg/m3  
Absorption coefficient 2.839 mm-1  
F(000) 1342  
Crystal size 0.20 x 0.16 x 0.14 mm3  
Theta range for data collection 3.33 to 65.20°.  
Index ranges -15<=h<=16, -12<=k<=12, -25<=l<=25  
Reflections collected 20233  
Independent reflections 5345 [R(int) = 0.0538]  
Completeness to theta = 65.20° 97.9 %   
Absorption correction Semi-empirical from equivalents  
Max. and min. transmission 0.6920 and 0.6005  
Refinement method Full-matrix least-squares on F2  
Data / restraints / parameters 5345 / 0 / 413  
Goodness-of-fit on F2 1.054  
Final R indices [I>2sigma(I)] R1 = 0.0464, wR2 = 0.1334  
R indices (all data) R1 = 0.0478, wR2 = 0.1350  
Largest diff. peak and hole 0.547 and -0.347 e.Å-3  
99 
 
Appendix B. Crystallographic data for 18-SA-MOM-trans-
SA 
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Figure B-1.  ORTEP plot of 18-SA-MOM-trans-SA.   
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Table B-1.  Crystal data and structure refinement for 18-SA-MOM-trans-SA 
Empirical formula  C23 H36 O8 S3  
Formula weight  536.70  
Temperature  173(2) K  
Wavelength  1.54184 Å  
Crystal system  Triclinic  
Space group  P -1  
Unit cell dimensions a = 8.3983(3) Å = 89.6800(10)°. 
 b = 11.4730(4) Å = 86.0480(10)°. 
 c = 13.4815(4) Å  = 78.2380(10)°. 
Volume 1268.65(7) Å3  
Z 2  
Density (calculated) 1.405 Mg/m3  
Absorption coefficient 3.064 mm-1  
F(000) 572  
Crystal size 0.11 x 0.09 x 0.09 mm3  
Theta range for data collection 3.29 to 65.08°.  
Index ranges -9<=h<=9, -13<=k<=13, -15<=l<=15  
Reflections collected 16072  
Independent reflections 4183 [R(int) = 0.0381]  
Completeness to theta = 65.08° 96.9 %   
Absorption correction Semi-empirical from equivalents  
Max. and min. transmission 0.7722 and 0.7372  
Refinement method Full-matrix least-squares on F2  
Data / restraints / parameters 4183 / 0 / 336  
Goodness-of-fit on F2 1.043  
Final R indices [I>2sigma(I)] R1 = 0.0441, wR2 = 0.1207  
R indices (all data) R1 = 0.0446, wR2 = 0.1214  
Largest diff. peak and hole 0.422 and -0.322 e.Å-3  
 
